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1 Zusammenfassung  
Der TRPV1 Rezeptor ist ein polymodal aktivierbarer Kationenkanal, der eine besondere 
Rolle in der Nozizeption einnimmt. Es ist bekannt, dass die positive Modulation der TRPV1 
Funktion durch Proteinkinase-vermittelte Phosphorylierungsprozesse zur Ausbildung von 
Hyperalgesie und/oder Allodynie beiträgt. Die vorliegende Studie hat das Ziel, die 
funktionellen Auswirkungen der Cdk5-vermittelten Phosphorylierung des TRPV1 
Rezeptors an Position Threonin-406 aufzuklären. Mit Hilfe von elektrophysiologischen 
Messungen konnten wir zeigen, dass die Koexpression von TRPV1 und Cdk5 in CHO Zellen 
eine Ca2+-abhängige Desensitisierung des TRPV1 Ionenkanals verhindert. Um den 
Zusammenhang zwischen Struktur und Funktion der TRPV1 Phosphorylierung durch die 
Cdk5 zu untersuchen, haben wir verschiedene TRPV1T406 Mutanten erstellt, welche durch 
Einfügen negativ geladener Aminosäurereste die Cdk5-abhängige Phosphorylierung am 
Threonin-406 imitieren, oder diese durch Ersetzen des Threoninrests mit Alanin 
inhibieren. Mit Hilfe elektrophysiologischer Ganz-Zell und Einzelkanal Messungen, sowie 
mit Ca2+-imaging und TIRF Mikroskopie, haben wir die Funktion dieser TRPV1T406 
Mutanten durch ihre Reaktion auf verschiedene Stimuli, wie Capsaicin, Hitze oder 
Protonen umfassend charakterisiert. Die Funktionsanalyse ergab, dass die Modifikation 
an Position T406 weitreichende Folgen für die Funktion des TRPV1 Ionenkanals haben 
kann. Das einbringen einer negativ geladenen Aminosäure, wie z.B. Asparaginsäure, 
veränderte die Ligandensensitivität, die Aktivierungs- und Desensitisierungskinetik sowie 
die Spannungsabhängigkeit des TRPV1 Ionenkanals. Die Einzelkanal Eigenschaften von 
TRPV1T406D Ionenkanälen zeigten ebenfalls deutliche Veränderungen, die auf einen 
veränderten Gating-Mechanismus des Rezeptors hindeuten. Unter Berücksichtigung der 
publizierten hochaufgelösten 3D Struktur des TRPV1 haben wir einen möglichen 
(mechanistischen) Übertragungsweg unter Beteiligung der Position 406 identifiziert und 
diesen Weg durch gezieltes Einbringen von Alanin-Resten und elektrophysiologischer 
Charakterisierung der TRPV1 Mutationen überprüft. Eine Störung des Übertragungsweges 
führte ebenfalls zu einer veränderten Funktion des TRPV1 Ionenkanals. Die Ergebnisse 
zeigen, dass die Position T406 des TRPV1 eine funktionelle Schlüsselrolle einnimmt und 
durch Phosphorylierung an der Modulation der Kanalfunktion beteiligt ist.  
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2 Summary  
The TRPV1 receptor is a polymodally activated cation channel acting as key receptor in 
nociceptive neurons. Its function is modulated by kinase-mediated phosphorylation, 
which contributes to the development of hyperalgesia and allodynia. In the present study, 
we demonstrate that TRPV1 function is strongly modulated by the Cdk5-mediated 
phosphorylation at amino acid residue T406. We observed that co-expression of TRPV1 
and Cdk5 prevents the Ca2+-dependent desensitization of the ion channel and has 
therefore severe consequences on receptor function. In order to understand the 
structural/functional consequences of TRPV1 phosphorylation in detail, we generated 
various TRPV1T406 receptor variants to mimic or inhibit the Cdk5-mediated 
phosphorylation. The function of these newly generated TRPV1T406 mutants was analyzed 
in a detailed characterization by means of electrophysiological whole-cell and single-
channel experiments as well as Ca2+-imaging and TIRF microscopy. TRPV1-mediated 
currents were induced by challenging TRPV1 expressing CHO or HEK293 cells with 
capsaicin, low pH or heat. Our results revealed that the function of TRPV1 receptors 
highly depends on position T406. The introduction of negatively charged amino acids (Asp 
or Glu) modulates the ligand-sensitivity, activation and desensitization kinetics as well as 
the voltage-dependence of TRPV1. Moreover, the analysis of the single-channel 
properties of TRPV1WT and TRPV1T406D revealed that the introduction of Asp at position 
T406 alters the ion channel gating mechanism. In order to investigate this gating 
mechanism in detail, we considered the high resolution 3D structure of TRPV1 and found 
a potential transition pathway putatively involved in the mechanistic processes provoking 
a conformational change of the protein and leading to the opening of the channel pore. 
By mutating various amino acid residues lining this transition pathway and 
electrophysiological analysis of the recombinant receptors, we could show that the 
introduction of a negative charge at position T406 induces conformational changes in the 
TRPV1 linker domain which influence the gating mechanism of the TRPV1 receptor. 
Therefore, we conclude that the Cdk5-mediated phosphorylation of TRPV1 at position 
T406 is an important molecular switch that influences the TRPV1-mediated nociception. 
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3 Introduction  
3.1 Nociception and pain  
The appropriate perception of noxious or potentially painful stimuli by nociceptors is 
crucial for life, since it prevents harm and injuries. Nociceptors are specialized sensory 
neurons of the trigeminal ganglion (TG) or the dorsal root ganglion (DRG). The free nerve 
endings in the periphery perceive noxious stimuli and transmit the information to specific 
nuclei in the central nervous system (Kandel et al. 2000). Trigeminal sensory neurons and 
dorsal root ganglion neurons are functionally and morphologically homologous, but the 
regions they innervate are different. Trigeminal sensory neurons innervate cranial 
structures such as face, lips, oral cavity, conjunctiva, and dura mater, whereas DRG 
neurons transmit information from the limbs and trunk (Kandel et al. 2000).  
Based on the stimulus type three classes of nociceptors can be distinguished: mechanical, 
thermal and polymodal nociceptors. Mechanical nociceptors are excited by tactile stimuli 
such as pinch or squeezing. Thermal nociceptors can be subdivided into nociceptors 
excited by noxious heat (temperatures above 45 °C) or noxious cold (temperatures below 
5 °C). Polymodal receptors were excited by various stimuli such as pinch, puncture, 
noxious heat or cold as well as irritant chemicals (Kandel et al. 2000). However, the nerve 
fiber that transmits the potential painful stimulus classifies the type of pain. Myelinated 
Aδ-fiber axons conduct the pain signal with an action potential speed of 
20 meters/second and induce the first or cutaneous pricking pain. The first pain has a high 
spatial resolution, is well localized and easily tolerated. The much slower conducting non-
myelinated C-fiber neurons only allow velocities of two meters/second inducing the 
second pain or burning pain which is poorly localized and poorly tolerated. In addition, 
pain arising from viscera, musculature and joints is called third or deep pain. Deep pain is 
also poorly localized and can be chronic or is associated with referred pain (Kandel et al. 
2000; Haslwanter et al. 2013). Moreover, several substances such as histamine, K+, 
bradykinin, substance P, protons, ATP, serotonin, and acetylcholine were released by 
injured and/or inflamed tissue, inducing the direct or indirect activation of nociceptors 
(Kandel et al. 2000).  
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In order to develop new medical active substances, that may help to relieve from pain, it 
is necessary to understand the molecular mechanism of pain transduction in detail. 
Therefore it is mandatory to investigate the molecular sensor, which initiates the signal 
transduction in nociceptors.  A milestone that improved the understanding of signal 
transduction in nociceptive neurons was the cloning and characterization of the capsaicin 
receptor transient receptor potential vanilloid 1 (TRPV1) by Caterina et al. (Caterina et al. 
1997). 
3.2 Transient receptor potential (TRP) ion channels  
The TRPV1 ion channel belongs to the transient receptor potential (TRP) ion channel 
superfamily. The first experiments that lead to the identification of the transient receptor 
potential family were done by Cosens and Manning. In the electroretinogram (ERG) of 
Drosophila melanogaster mutants, they found a short transient response during bright 
light exposure (Cosens & Manning 1969). But it took another 20 years to identify the 
mutated gene locus, finally Montell and Rubin cloned the gene containing the mutation 
and termed it transient receptor potential (TRP) (Montell & Rubin 1989). Until today, 28 
different mammalian TRP ion channels were identified and constitute one of the largest 
ion channel family, the TRP superfamily (Fig. 1).  
 
Figure 1. Phylogenetic tree of the mammalian TRP-superfamily by Gees et al. including six 
subfamilies and 28 ion channels (Gees et al. 2010). 
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The mammalian TRP superfamily can be subdivided into six subfamilies: the TRPC1-7 
(canonical), TRPV1-6 (vanilloid), TRPM1-8 (melastatin), TRPA1 (ankyrin), TRPP1-3 
(polycystin) and TRPML1-3 (mucolipin) (Clapham 2003). All TRP channels consist of four 
subunits and each subunit includes six transmembrane domains (S1-S6), with a pore-
forming loop between the fifth and sixth transmembrane domain and cytoplasmatic 
located amino (N-) and carboxyl (C-) termini (Minke & Cook 2002). These regions are well 
known and include domains and motifs that are involved in channel assembly, activation, 
and regulation. TRP ion channels are non-selective cation channels that respond to a 
variety of physical and chemical stimuli such as temperature, mechanical force, 
osmolality, and chemical components (Minke & Cook 2002). Additionally, is the TRP 
channel function and expression triggered by several modifications such as 
phosphorylation, dephosphorylation, G-protein-coupling or phosphateidylinositol-4,5-
biphosphate (PIP2) binding (Venkatachalam & Montell 2007). The polymodal activation 
and regulation of the TRP ion channels is very important in the sensory system of animals, 
espacially the thermal and chemical activation of TRPV1-TRPV4, TRPM8 and TRPA1 
(Dhaka et al. 2006). 
3.3 TRPV ion channel subfamily  
The TRPV1 is the first member of the TRPV subfamily which includes six ion channels 
(TRPV1-TRPV6) (Gunthorpe et al. 2002). Characteristic for the TRPV subfamily members is 
the large N-terminal domain, which contains six Ankyrin repeat domains (ARD) (Latorre et 
al. 2009; Jung et al. 2002) and the polymodal activation by several physical and chemical 
(vanilloids) stimuli. Interestingly, TRPV1-TRPV4 ion channels are also molecular 
thermosensors with different thermal thresholds. Several studies using DRG or TG 
neurons or the overexpression of TRPV ion channels in HEK, CHO cells or frog oocytes 
revealed the different threshold temperatures of TRPV1 (~42°C), TRPV2 (~52°C), TRPV3 
(~33°C) and TRPV4 (~27°C) (Patapoutian et al. 2003). The activation of TRPV1-TRPV4 
receptors induces the non-selective influx of cations through the ion channel pore, 
whereas the activation of TRPV5 and TRPV6 receptors leads to an highly selective Ca2+ 
influx (Vennekens et al. 2000; Yue et al. 2001). The polymodal activation and modification 
of TRPV ion channels in nociceptors, particularly the TRPV1 receptor, qualifies them as 
pharmacological targets. 
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3.4 Structural and functional features of the TRPV1 receptor  
The structure of the TRPV1 ion channel was investigated for a long time, but due to 
technical limitations the resolution of the TRPV1 3D structure was very low 
(Moiseenkova-Bell et al. 2008). Only the 3D structure of the N-terminal located ankyrin 
repeat domain (ARD) was provided at relative high-resolution by Lishko et al. (Lishko et al. 
2007). However, the further development of the electron cryo-microscopy facilitated Cao 
et al. and Liao et al. to provide a high-resolution 3D structure of TRPV1 in the closed and 
open state as well as in an intermediate state (Cao et al. 2013; Liao et al. 2013). Based on 
these detailed 3D structures of the TRPV1 (Fig. 2), the following is a description of the 
most important structures and domains of the TRPV1 ion channel. 
 
Figure 2. 3D structure of the TRPV1 ion channel by Liao et al. presented as ribbon 
diagram. (a) Side view on the four subunits, each subunit consisting of six transmembrane 
domains and intracellular located N- and C- termini (b) Bottom view on the six 
transmembrane domains (TMD) including TMD 1-4 and TMD 5-P-6 with the central pore 
(Liao et al. 2013). 
The intracellular N-terminus of the TRPV1 includes six ankyrin repeats and the linker 
domain (P360-V415), which connects the ARD to the pre-TMD 1 helix. Ankyrin repeats are 
characterized by 33-residues that form two α-helices which were connected by loops. It is 
assumed that the TRPV1 ankyrin repeat domains are involved in ion channel assembly 
and subunit-subunit interaction (Erler et al. 2004; Hellwig 2005), which was verified by 
the high resolution structure of the TRPV1.  
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Cao et al. have shown that an atypical extended loop and two helices of ankyrin repeats 3 
and 4 interact with a C-terminal β-strand (Cao et al. 2013). Additionally, the ARD surface 
forms an extensive cytoplasmic area that is proposed to facilitate the binding and 
interaction with calmodulin and ATP (Lishko et al. 2007). The linker domain connects the 
ARD to the pre-TMD 1 helix and includes β-strands as well as α-helices. The tightly packed 
domain is located between the six ankyrin repeats on the N-terminal side and the 
pre-TMD 1 helix and TRP domain on the C-terminal side. The interaction of two β-strands 
from the linker domain with two ankyrin repeats of an adjacent C-terminal subunit 
indicates that the linker domain is important for TRPV1 ion channel assembly. 
Furthermore, the linker domain contains an extended and kinked helix, which has 
equivalent characteristics as the TRP domain. This helix probably affects the ion channel 
gating since it is strategically located to interact with the TMD 4-5 linker and the 
pre-TMD1 helix (Fig. 3) (Liao et al. 2013). The six transmembrane domains of TRPV1 are 
structured into two sections, the surrounding transmembrane domains 1-4 and the 
central pore forming TMD 5-P-6 section.  
 
Figure 3. TRPV1 structure by Liao et al. (a) Schematic and (b) ribbon diagrams of one 
TRPV1 subunit, color code of the linear diagram matches to the ribbon diagram (S = TMD) 
(Liao et al. 2013). 
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The transmembrane domains 1-4 are connected to the TMD 5-P-6 section of an adjacent 
subunit, establishing a pinwheel-like structure. In contrast to the pore forming TMD 5-P-6 
region is the transmembrane domain 1-4 section a solid anchor which is relative 
stationary during channel activation, but provides the binding of lipophilic ligands such as 
capsaicin or Resiniferatoxin (RTX). Connection between the transmembrane domain 1-4 
and the TMD 5-P-6 section is provided by the flexible TMD 4-5 linker that facilitates the 
ion channel gating. The TRPV1 ion channel pore is divided into three compartments, the 
outer pore region, the central selectivity filter, and the lower gate (Liao et al. 2013). 
Compared to KV channels is the outer pore of the TRPV1 relatively wide open and has a 
broad funnel-like structure. The central selectivity filter has a relative small diameter and 
consists of the amino acids 643GMGD646, in which side chains or backbone carbonyls point 
into the central pore and form the permeation pathway. In the non-conducting or closed 
state the restriction point was found between diagonally opposed carbonyl oxygens at 
G643 (4.6 Å). Whereas in the activated or open state the diameter of the selectivity filter 
is increased. Interestingly, no hydrogen bonding was found between the adjacent pore 
helices of TRPV1 receptors, which results in a flexible architecture that might provide the 
phenomenon of pore dilatation. A pore dilatation occurs when the TRPV1 is repetitively 
or prolonged activated and lead to a dilatated pore which is permeable for large organic 
cations. The lower gate consists of the four I679 amino acid residues that form in the 
closed state a hydrophobic seal with a distance of 5.3 Å between the specific side-chain 
atoms. During the opening process several rearrangements occur in the selectivity filter 
and the inner pore (Liao et al. 2013). To investigate these rearrangements Cao et al. 
analyzed the TRPV1 structure in distinct conformations the apo TRPV1 structure, the 
capsaicin-bound, and the RTX/DkTx-bound. In the apo TRPV1 structure the widening of 
the selectivity filter and the lower gate were at its narrowest point at G643 4.6 Å and I679 
5.3 Å, representing the closed TRPV1 ion channel. The capsaicin-bound TRPV1 is in an 
intermediated state, whereas the selectivity filter is unaffected, but the lower gate is 
significantly widened to a diameter of 7.6 Å. In the RTX/DkTx-bound TRPV1, representing 
the open TRPV1 ion channel, the selectivity filter is expanded to 7.7 Å at G643 and the 
lower gate is widened to a diameter of 9.3 Å.  
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In conclusion, the three conformations of the TRPV1 revealed that the TRPV1 ion channel 
pore acts as dual gate(Cao et al. 2013). Just after the pore forming TMD 6 is the TRP 
domain located, the TRP domain has 23-25 amino acids and can be found in many TRP 
family members. The TRP domain is a α-helical structure that includes a sharp bend after 
the TMD 6 and runs parallel to the inner membrane. The first two-thirds of the TRP 
domain were organized as α-helix, while the rest shifts into a random coil structure. 
Interestingly, the amino acid W697, which is close to the middle of the TRP domain forms 
hydrogen bounds with the F559 of the S4-S5 linker (Cao et al. 2013). Additionally, it was 
shown in a W697 mutagenesis study that the disruption of the hydrogen bound notably 
affects the voltage and capsaicin evoked TRPV1 channel gating (Gregorio-Teruel et al. 
2014). The detailed insights into the TRPV1 3D structure may help to understand the 
molecular mechanisms that occur during TRPV1 activation and/or modification.  
3.5 Activation and inhibition of TRPV1  
TRPV1 receptors are ligand-gated non-selective cation channels, that conduct Ca2+ with a 
9x higher preference over Na+ (Chung et al. 2008). The TRPV1 is polymodally, activated by 
several exogenous and endogenous chemical and physical stimuli such as the vanilloid 
capsaicin, protons, heat or voltage (Cortright & Szallasi 2004). However, capsaicin and its 
biological analogs as well as protons are sensitizers, since it binding lowers the voltage 
activation threshold of TRPV1, but due to the direct binding, it is by convention allowed to 
call them activators. In contrast, compounds that affect the TRPV1 function indirectly 
without binding were called sensitizers (Vriens J. et al. 2009). Activation of the TRPV1 
opens the pore and cations flow through the permeation pathway. Under physiological 
conditions, the electrochemical gradient drives cations from the extracellular into the 
intracellular compartment, but TRPV1 is also conductive in the opposite direction. 
Furthermore, the TRPV1 ion channel is outwardly-rectifying and has a reversal potential 
of 0 mV (Voets et al. 2004; Caterina et al. 1997). One of the first known TRPV1 activators 
is Capsaicin. It is a specific TRPV1 agonist and the active ingredient in chili peppers that 
induces in mammals a burning hot sensation (Caterina et al. 1997). The identification of 
the capsaicin-binding site in the mammalian TRPV1 is interesting.  
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Since birds does not perceive burning hot sensation induced by capsaicin, Jordt and Julius 
compared the TRPV1 protein sequences and located the capsaicin binding site between 
TMD 3 and TMD 4 involving the amino acid residues Y511, T512, M547, and T550 (Jordt & 
Julius 2002). The most effective naturally stimuli that activates the TRPV1 is the diterpene 
Resiniferatoxin (RTX); which is a chemical compound of Euphorbia resinifera (Szallasi & 
Blumberg 1989), RTX activates the TRPV1 almost 20x more potent than capsaicin 
(Caterina et al. 1997). But the TRPV1 ion channel is also activated by molecules with 
similar structures such as quinazoline (Culshaw et al. 2006), evodiamine (Pearce et al. 
2004) and 17-β-estradiol (Xu et al. 2008), as well as molecules with long acyl and amid 
chains, such as anandamide (Ross 2003), olvaniol, and omega-3 polyunsuturated fatty 
acids (Jara-Oseguera et al. 2008). Further TRPV1 agonists are 12-HPETE (Hwang et al. 
2000), anandamide (Ross 2003), NADA (Premkumar et al. 2004), AEA (Price et al. 2004), 
piperine (McNamara et al. 2005), eugenol (Yang et al. 2003), zingerone (Liu & Simon 
1996) and gingerols (Dedov et al. 2002). Apart from the activation by chemical 
compounds the TRPV1 is activated by low pH, via interaction of protons with amino acid 
residues in the outer pore domain E600, E648, F660. To activate the TRPV1 properly, a pH 
below 6 is required, but even small pH changes (pH 6-7) sensitize the receptor sensitivity 
to capsaicin or heat (Aneiros et al. 2011; Caterina et al. 1997; Jordt et al. 2000). In 
contrast to the wide variety of TRPV1 agonists, competitive TRPV1 antagonists are rare. 
Capsazepine was identified as first competitive antagonist for TRPV1, capsazepine 
competes with capsaicin for the capsaicin-binding site and can also displace RTX from its 
binding site. However, the potency of capsazepine is species-specific, while it is relative 
potent at human TRPV1, it is much less potent ats rat TRPV1 (Liu & Simon 1997; Docherty 
et al. 1997). Other TRPV1 antagonists are Thapsigargin which is also a potent ATPase 
inhibitor (Tóth et al. 2002) as well as Yohibine an indole alkaloid that inhibits the TRPV1-
induced firing activity of DRG neurons (Dessaint et al. 2004). Endogenous TRPV1 
antagonists are dynorphins, a natural arginine-rich peptide, adenosine, fatty acids such as 
eicosapentaenoic or linolenic acids, and also polyamines have been reported to block 
TRPV1 (Matta et al. 2007; Puntambekar 2004). Additionally, some noncompetitive 
antagonists were known, for example Ruthenium Red (RR), which not interacts with the 
ligand binding site of TRP ion channels but blocks the pore.  
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Interestingly, the RR induced pore block is voltage-dependent, i.e. inward currents were 
blocked but outward currents were unaffected (Caterina et al. 1997). The classic K+ 
blocker tetrabutylammonium (TBA) also blocks the TRPV1 in a voltage-dependent 
manner, but it blocks the TRPV1 in the open state by interfering with the closing of the 
lower gate (Oseguera et al. 2007). In summary, the polymodal activation and inhibition of 
the TRPV1 ion channels by exogenous and endogenous stimuli facilitates the 
development of new tools for pain treatment.  
3.6 Regulation of TRPV1 receptors  
As already mentioned TRPV1 activation involved in pathophysiological conditions such as 
allodynia and hyperalgesia, therefore it is necessary to investigate the molecular 
mechanisms of TRPV1 ion channel regulation in more detail (Caterina et al. 2000; Bölcskei 
et al. 2005; Christoph et al. 2006). For instance damaged tissue releases several 
inflammatory mediators such as growth factors, neurotransmitters, peptides or small 
proteins, lipids, chemokines and cytokines, which results in the sensitization of 
nociceptors (Ma & Quirion 2007). Via different pathways including receptor tyrosine 
kinases or G-protein-coupled receptors, inflammatory mediators affect TRPV1 function by 
kinase-mediated phosphorylation. Phosphorylation in general affects the steric and 
electric properties of amino acids and lead to conformational changes in the adjacent 
structures (Johnson & Barford 1993). It is known that phosphorylation of TRPV1 receptors 
increases their sensitivity to endogenous and exogenous stimuli such as capsaicin, 
protons, or heat and formerly non-activating concentrations or stimuli become activating 
(Fig. 4). TRPV1 is phosphorylated by several kinases: protein kinase A (PKA) (Lopshire & 
Nicol 1998; De Petrocellis et al. 2001; Varga et al. 2006), protein kinase C (PKC) (Cesare et 
al. 1999; Premkumar & Ahern 2000; Vellani et al. 2001), Ca2+/CaM-dependent kinase II 
(CaMKII) (Jung et al. 2004) and Src kinase (Jin et al. 2004) (Fig. 5). While, the kinase-
mediated phosphorylation sensitizes TRPV1 receptors, the dephosphorylation 
desensitizes the TRPV1 receptors. Cytosolic Ca2+ and calmodulin form a 
Ca2+/calmodulin-complex, which activate the protein phosphatase calcineurine (CaN) 
dependent dephosphorylation of TRPV1 receptors. The desensitization of TRPV1 
decreases the spontaneous activity of TRPV1 and reduces the stimuli-mediated activity 
(Lishko et al. 2007; Koplas et al. 1997). 
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Figure 4. TRPV1 activation and regulation by Ho et al. (left side) GPCR-induced activation 
of the adenylate cyclase pathway facilitates the PKA-mediated phosphorylation of the 
TRPV1. Ca2+/Calmodulin (CaM)-complex activates CaMKII, which phosphorylates TRPV1. 
(right side) GPCR-mediated activation of PLC cleaves PIP2 into IP3 and DAG, latter induces 
the PKC-mediated phosphorylation of TRPV1 receptors. (center) Polymodal activation of 
TRPV1 induces cation influx, Ca2+ binds to calmodulin (CaM) and activates the 
phosphatase Calcineurin (CaN) which dephosphorylates the TRPV1 (Ho et al. 2012).  
 
Figure 5. Functionally important amino acids and segments of the TRPV1 receptor by Ho 
et al. Color coded phosphorylation sites of PKA, PKC, and CaMKII as well as capsaicin and 
proton binding sites. Structural important domains of TRPV1 such as ankyrin repeat 
domains, transmembrane domains, pore region, and the TRP domain including the TRP-
box. ATP and calmodulin binding side of at intracellular located N- or C- termini (Ho et al. 
2012).  
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Furthermore is the TRPV1 modulated by PIP2 in the first instance it was shown that PIP2 
binds to TRPV1 and inhibits TRPV1 activity, which was demonstrated by PLC-mediated 
hydrolysis and antibody-mediated block of PIP2 (Prescott & Julius 2003; Chuang et al. 
2001). But in recent studies it was shown that the decrease of PIP2 correlates with 
reduced activity of TRPV1, e.g. PIP2 binding increases the TRPV1 ion channel activity 
(Lukacs et al. 2007; Yao & Qin 2009; Ufret-Vincenty et al. 2011; Stein et al. 2006). 
Therefore, it is necessary to study the modification of the TRPV1 function in order to 
develop new analgesic drugs. In particular, the phosphorylation and dephosphorylation of 
TRPV1 receptors is an important target.  
3.7 TRPV1 and Cyclin-dependent kinase 5  
In 2006 Pareek et al. showed that Cdk5 and the neuron-specific activator p35 were 
expressed and active in nociceptors such as DRG or TG neurons. They also revealed that 
the Cdk5 protein level and activity were increased during carrageenan-induced 
inflammation. Moreover, they found in genetically engineered mice that the 
overexpression of p35 (Tgp35) increased the Cdk5 activity and led to hyperalgesia, 
whereas the knockout of p35 provoke a decreased Cdk5 activity and induced hypoalgesia 
(Pareek et al. 2006). Therefore, they assume that during inflammatory processes the Ca2+ 
influx into nociceptors increases, which catalyzes the Ca2+-dependent protease calpain. 
Calpain dependent hydrolysis of p35 in p25 and p10, p25 in turn increases Cdk5 activity. 
That was supported by a study of Yang et al., which showed that primary sensory neurons 
express Cdk5 and p35 and that the injection of Freud’s complete adjuvant (CFA) increases 
the Cdk5 activity. Additionally, they could associate the increased Cdk5 activity to 
hyperalgesia (Yang et al. 2007). Thus, Kulkarni et al. investigated the signal transduction 
mechanism that is responsible for the modulation of nociceptive transmission in sensory 
neurons. They associated the Cdk5 activity to the MAPK signaling pathway by proposing 
that Cdk5/p35 regulates the MEK1/2 activity via a negative feedback loop (Pareek et al. 
2006). Simultaneously, they investigated the downstream target of the signal cascade and 
could show in 2007 that the Cdk5 directly phosphorylates TRPV1 receptors. Subsequently, 
they analyzed the TRPV1 sequence for putative Cdk5 consensus sites (S/T)PX(K/H/R) and 
found three putative consensus sites: threonine-108 (TPPR), threonine-407 (TPNR) and 
serine-612 (SPPH).  
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Alignment of different mammalian TRPV1 protein sequences revealed that threonine-407 
is highly conserved among different species. To demonstrate that the endogenous TRPV1 
was phosphorylated by Cdk5, the TRPV1 of genetically engineered Cdk+/+ and Cdk-/- mice 
was tested in kinase assays by using a specific P-TRPV1 antibody. Furthermore, they 
investigated the effect of the Cdk5-dependent phosphorylation on TRPV1 function. 
Therefore, a Ca2+ influx assay with DRG neurons was performed revealing that the 
inhibition of Cdk5 activity reduces TRPV1-mediated Ca2+ influx. Finally, it was shown that 
the lack of Cdk5 in DRG neurons prevents the phosphorylation of TRPV1 at position T407 
and induced hypoalgesia (Pareek et al. 2007). In 2011 Uteras at al., identified the signal 
transduction pathway in odontoblast-like MDPC-23 cells. They found that during a 
bacterial inflammation, TGF-β1 was released into the extracellular matrix and the 
associated TGF-β1 receptor 1 activates Smad-dependent and independent pathways. 
These pathways increase the Egr-1 and p35 expression, which in turn activates Cdk5 
kinase that phosphorylates TRPV1 receptors (Fig. 6). The TRPV1 phosphorylation results in 
enhanced Ca2+ influx into odontoblast cells, which may induce more action potentials and 
an increased transmitter release (Utreras et al. 2013). To further investigate the impact of 
Cdk5 activity on TRPV1 function in detail, our cooperation partners Kulkarni et al. 
performed several behavioral experiments (Jendryke et al. 2016). They tested the pain 
tolerance of mice with either increased or decreased Cdk5 activity by treating the animals 
with stimuli that are known to activate TRPV1. Therefore, the sensitivity to capsaicin was 
tested in the different genotypes. The oral administration of capsaicin induces a burning 
sensation and reduces the drinking behavior of mice. Training sessions (water only) 
allowed the animals to habituate to the lickometer and the basal licking behavior of each 
genotype was determined. The training sessions revealed no difference in the licking 
behavior of different mice strains. To investigate the TRPV1-mediated aversive behavior, 
15 µM capsaicin were adjusted in the drinking water. Compared to the basal licking 
behavior, capsaicin reduced the licking behavior of C57BL6WT mice to 16.2%, whereas the 
licking behavior of p35 KO mice decreased to 35.5% and in Cdk5 CoKo mice to 29.5% (Fig. 
7). 
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Figure 6. Putative TNFα-induced pathway based on the findings of Pareek at al., TNF binds 
to TNF-receptors and activates the MEKK1/2-ERK1/2 signaling cascade, which induces the 
Cdk5-mediated phosphorylation of TRPV1.  
The statistical analysis revealed that in the presence of capsaicin the licking behavior of 
Cdk5 or p35 knockout mice is less affected than the licking behavior of wild-type mice, 
whereas the licking behavior of TRPV1 KO mice was unaffected (94.7%). These data 
revealed that the reduced activity or the lack of Cdk5 increases the pain tolerance to 
TRPV1 specific stimuli. Challenging FVBN WT mice with 15 µM capsaicin reduced the 
licking behavior to 51.8%, whereas the licking behavior of FVBN Tgp35 mice was reduced 
to 36.2%. Comparison of the licking behavior of FVBN wild-type and Tgp35 mice revealed 
that Tgp35 mice were significantly more sensitive to 15 µM capsaicin than the WT mice 
(unpaired t-test p < 0.05) (Fig. 7). These data indicate that an increased p35 activity 
sensitizes the nociceptors to capsaicin, probably by promoting Cdk5-mediated 
phosphorylation of TRPV1. 
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Figure 7. Effect of capsaicin on drinking behavior of wild-type, p35 KO, Cdk5 CoKo, TRPV1 
KO and Tgp35 mice. Water deprived mice were tested in the lickometer device with a free 
access initially to plain water (for training), then to water containing different 
concentrations of capsaicin. The licking behavior at 15 μM capsaicin, is presented as % of 
the basal licking behavior (plain water). Compared to wild-type, the licking behavior of 
p35 KO or Cdk5 CoKo was significantly less reduced, while the Tgp35 mice showed a 
significantly increased sensitivity to 15 µM capsaicin leading to reduced drinking behavior. 
Data were presented as mean ± SEM from four animals during five different 
measurements (One-way Anova ***p < 0.001, unpaired t-test *p < 0.05) (Jendryke et al. 
2016). 
Since the TRPV1 receptor is activated by hot temperatures Kulkarni et al. set out to 
investigate the thermal nociception of the genetically engineered mice (Jendryke et al. 
2016). Therefore, the OPAD system (Orofacial Pain Assessment Device, Stoelting) was 
used to measure the licking behavior of mice in the presence of noxious heat. At 37 °C, 
the consumption of 30% sucrose was equal in all genotypes (Fig. 8a), but increasing the 
temperature to 45 °C induced an altered licking behavior (Fig. 8b). The licking behavior of 
C56BL6WT mice was significantly reduced, whereas the licking behavior of p35 KO and 
Cdk5 CoKo mice was nearly unchanged (unpaired t-test p < 0.05). In FVBN mice the licking 
behavior was reduced by 45 °C, but mice overexpressing p35 were significantly more 
sensitive than wild-type mice. The unaffected licking behavior of p35KO and Cdk5 CoKo 
mice as well as the decreased licking behavior of mice overexpressing p35 indicates that 
Cdk5 activity strongly affects the heat tolerance of mice. In conclusion, the in vivo results 
reveal that an increased or decreased Cdk5 activity has severe consequences on the 
TRPV1-mediated nociception. Increased Cdk5 activity induces hyperalgesia and allodynia, 
whereas the lack of Cdk5 or a reduced Cdk5 activity induces hypoalgesia. The increased 
TRPV1 sensitivity is probably a result of direct phosphorylation of TRPV1 by Cdk5, but 
until today hardly any functional characterization of the Cdk5-mediated phosphorylation 
of the TRPV1 is published. Therefore, we set out to investigate the effect of Cdk5-
dependent phosphorylation of TRPV1 in vitro.  
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Figure 8. Impact of heat on the licking behavior of wild-type, p35 KO, Cdk5 CoKo and 
Tgp35 mice. (a) At 37 °C, all mice showed similar consumption rates of the sucrose 
reward. (b) At 45 °C, the Tgp35 mice revealed an aversive licking behavior, while the p35 
KO mice showed a significantly increased number of licks compared to wild-type controls. 
Data are presented as mean ± SEM from four animals measured five times using 37 °C 
and three times at 45 °C (unpaired t-test  *p < 0.05, ***p < 0.001) (Jendryke et al. 2016). 
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4 Aims 
In order to investigate the effect of Cdk5-mediated phosphorylation on the TRPV1 ion 
channel function, we set out to analyze 
 the impact of Cdk5-mediated phosphorylation of TRPV1 in vitro. 
 The Ca2+-dependent desensitization and capsaicin sensitivity of TRPV1 receptors 
will be characterized by means of electrophysiological experiments using CHO cells 
co-expressing a combination of TRPV1, Cdk5, and p35. 
the effect of TRPV1T406 mutagenesis on the ion channel function. 
 The activation and desensitization kinetics, the sensitivity to capsaicin or protons 
as well as the voltage-dependence of TRPV1T406 mutants will be characterized by 
means of electrophysiological whole-cell recordings of transfected CHO cells.  
 The heat sensitivity of TRPV1T406 mutants, generated to mimic or inhibit the Cdk5-
mediated phosphorylation of TRPV1, will be analyzed by means of Ca2+-imaging 
experiments in transfected HEK293 cells. 
 The plasma membrane expression of GFP-tagged TRPV1T406 mutants, will be 
investigated by means of TIRF microscopy. 
 The ion channel gating mechanism of TRPV1WT and TRPV1T406D single-channels will 
be characterized by means of electrophysiological cell-attached recordings of 
transfected CHO cells. 
the transition pathway which connects the Cdk5-mediated phosphorylation of T406 to 
the TRPV1 gating mechanism. 
 The activation and desensitization kinetics, the sensitivity to capsaicin or protons 
as well as the voltage-dependence of TRPV1 transition pathway will be analyzed 
by means of electrophysiological whole-cell recordings of CHO cells expressing 
TRPV1 double mutant receptors. 
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5 Methods 
5.1 Molecular biological methods   
The plasmids used in this thesis were provided by Prof. Dr. D. Julius, University of 
California, USA (pcDNA3-rTRPV1), Prof. Dr. M. Hollmann, Ruhr-Universität Bochum, 
Germany (pcDNA3-GFP), Prof. Dr. A. Kulkarni, NIH/NIDCR, Bethesda, USA (pcDNA3-Cdk5, 
pcDNA3-p35), Dr. V. Milenkovic, UKR, Germany (pGEM-T). The pcDNA3 vector is a 
mammalian expression vector including the CMV promotor, a multiple cloning site (MCS), 
and the bacterial resistance ampicillin. Reproduction or manipulation of coding DNA 
(cDNA) requires various molecular methods that were described in the following. 
5.1.1 Chemocompetent E.coli bacteria   
In order to amplify pcDNA3 vectors we utilized chemocompetent Escherichia coli bacteria 
cells (DH5α). Therefore, 50 µl of the E. coli glycerol stock were plated onto a LB-agar plate 
and incubated overnight at 37 °C. The next day, one colony was picked and transferred 
into 4 ml of LB-medium and grew overnight in a hot air shaker (120 rpm) at 37 °C. 500 µl 
of this preparatory culture were diluted into 750 ml of LB medium and incubated in a hot 
air shaker at 37 °C. The cell growth was stopped at OD600 0.5-0.7 by cooling the bacteria 
solution on ice for 15 min and centrifugation at 3500 x g and 4 °C. The supernatant was 
discarded, and the pellet was resuspended in 125 ml ice-cold 0.1 M MgCl2 and incubated 
for 10 min on ice. In a second centrifugation step at 4 °C and 2500 x g for 10 min the 
bacteria were pelleted again. After discarding the supernatant, the pellet was 
resuspended in 60 ml 0.1 M CaCl2 and incubated for 20 min on ice. In a last centrifugation 
step at 4 °C and 2500 x g for 10 min the bacteria were collected (discard the supernatant) 
and finally resuspended in 12 ml 85 mM CaCl2 + 15% glycerol. 100 µl aliquots of the 
chemocompetent E. coli DH5 α were shock-frozen and stored in 1.5 ml Eppendorf tubes 
at -80 °C.  
5.1.2 Transformation of vectors into chemocompetent bacteria  
In order to introduce coding DNA into chemocompetent E. coli, one bacteria aliquot was 
thawed on ice and 20-50 ng of ligation product or 5-20 ng of vector DNA was added.  
After 30 min on ice the transformation mixture was heat shocked at 45 °C for 45 seconds 
and subsequently incubated on ice for 1 min. 500 µl SOC medium were added and the 
Methods 
20 
 
mixture was incubated on a thermal shaker at 90 rpm and 37 °C for 60 min. Finally, 100 µl 
of the bacteria were spread on LBampicillin plates and incubated overnight at 37 °C. Once 
the transformation of the pcDNA-TRPV1 vector was successful, only the ampicillin 
resistant bacteria survived and appeared as colonies on the LBampicillin-agar plate. 
5.1.3 Isolation of plasmid DNA  
In order to isolate plasmid DNA from transformed bacteria, one successfully transformed 
colony was inoculated into LBampicillin medium and incubated at 37 °C in a hot air shaker at 
150 rpm. 5 to 100 ml of saturated E. coli culture were used for Mini-preparation or 
Midi/Maxi-preparation (Quiaprep Spin Mini, Midi, Maxi-prep Kit, Qiagen, Hilden, 
Germany), depending on the amount of plasmid DNA needed. The preparation was 
performed by the manufacturer’s protocol, the Plasmid DNA amount and quality was 
quantified by Nanodrop spectrophotometry (NanoDrop Technologies, Wilmington, USA) 
as well as agarose gel electrophoresis. 
5.1.4 Restriction digestion of plasmid DNA  
Digestion of Plasmid DNA was performed by restriction enzymes. The restriction mix is an 
aqueous solution, which contains 0.2-5 µg of DNA, 5 µl of 10x restriction enzyme buffer, 
and 1 µl of restriction enzyme (final volume = 50 µl). Depending on the optimal working 
temperature of the restriction enzyme the mixture was incubated for 1-2 hours at the 
appropriate temperature (usually 37 °C). In order to verify the digestion and to separate 
the DNA by their length we used the agarose gel electrophoresis.  
5.1.5 Agarose gel electrophoresis  
The agarose gel electrophoresis technique separates DNA fragments by their length in 
base pairs. In the electric field of the gel electrophoresis, large DNA fragments migrate 
slower than small DNA fragments. To prepare a 1% agarose gel we mixed and boiled 1 g 
agarose and 100 ml 1 x TAE-buffer, and added 3 µl ethidium bromide to visualize the DNA 
under UV-light. The hot mixture was transferred into the gel chamber to let the gel 
polymerize for 30-60 minutes. DNA fragments were separated by applying 120-140 V for 
about 1 h and visualized by means of a UV-camera. Finally, the size of the DNA fragments 
was determined by comparison to 1 kb Plus DNA Ladder (Invitrogen, Karlsruhe, Germany). 
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5.1.6 Gel extraction  
In order to extract DNA fragments from agarose gels we used the NucleoSpin Extract kit 
(Macherey Nagel, Düren, Germany). The gel slice including the target DNA was cut out 
and dissolved in NTI buffer at 50 °C for 5-10 min. Then the DNA was washed twice with 
NT3 buffer utilizing a clean-up column and centrifugation for 30 s at 11000 x g. Finally, the 
clean DNA fragments were eluted in 20 µl dH2O and collected in a fresh 0.5 ml Eppendorf 
tube.  
5.1.7 Ligation of digested DNA fragments  
In order to ligate the purified DNA fragments the T4 DNA ligase (Promega) was used. The 
10 µl reaction volume contained digested and purified vector DNA and insert DNA as well 
as 1 µl 10x ligase buffer, and 1 µl of T4 DNA ligase. Depending on the relative size of the 
insert and the vector DNA the amount of vector and insert DNA ranges between 
equimolar ratios to ratios of 1:10 (vector:insert). The ligation reaction was incubated 
overnight at 14 °C.  
5.1.8 Polymerase chain reaction (PCR)  
In order to amplify DNA we used the polymerase chain reaction (PCR) adapted from Saiki 
(Saiki et al. 1988). The PCR mix is an aqueous solution that contains a polymerase specific 
reaction buffer, which provides the optimal chemical environment for the DNA 
polymerase, and the four triphosphate nucleotides: adenine, guanine, cytosine, and 
thymine. Additionally, the PCR mix contains the DNA template (50-100 ng) a 
complementary primer pair that binds to the sense and anti-sense strand of the DNA as 
well as the DNA-polymerase, which amplifies the DNA. To generate error free DNA 
replicates the proofreading PfuUltra HF DNA Polymerase (Aglient) was used. The reaction 
tubes containing the PCR mix were placed in a thermocycler, which heats and cools the 
PCR mix. The thermocycler performs three discrete temperature changes in 25-35 cycles. 
Initially, the PCR mix was heated up to a temperature of 94 °C for 10 min to activate the 
DNA polymerase (i). In the first step of the PCR cycle this temperature of 94°C was held 
for 1 min (ii). At that time, the double-stranded DNA was separated into two 
single-stranded DNA molecules, by disrupting the hydrogen bonds between the 
complementary bases. In the annealing step, the temperature was lowered to 50-65 °C to 
allow the oligonucleotide to anneal to the complementary sequence of the target DNA. 
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The annealing temperature is very critical, since low temperatures lead to insufficient 
primer bindings and high temperatures lead to unspecific primer bindings. The last step of 
the PCR cycle is the elongation step, its temperature depends on the optimum activity 
temperature of the used DNA polymerase. For the PfuUltra HF DNA Polymerase we set 
the temperature to 72 °C (iv). The synthesis velocity of the DNA polymerase was about 
1000 bases/min, therefore the elongation time depends on the length of the DNA 
fragment to amplify. A final elongation step at 72 °C for 10 min was performed after the 
last PCR cycle to make sure that all remaining single-stranded DNA were fully amplified 
(v). Finally the temperature was set to 15 °C for infinity time (vi) (Fig. 9).   
 
Figure 9. PCR temperature steps: (i) initial, (ii) denaturation, (iii) annealing, (iv) 
elongation, (v) final elongation, and (vi) final holding temperature.  
5.1.9 Cloning of Cdk5-mCherry, p35-CFP, and TRPV1-GFP fusion proteins  
In order to identify TRPV1 transfected CHO cells we co-transfected the cells with TRPV1 
and green fluorescent protein (GFP) coding DNA. To identify cells co-expressing TRPV1, 
Cdk5, and p35, we C-terminally tagged Cdk5 and p35 with either red-fluorescent protein 
mCherry or cyan-fluorescent protein CFP, respectively. Therefore, we subcloned the cDNA 
of mCherry or CFP into the pcDNA3-Cdk5 or pcDNA3-p35 vector, respectively. The coding 
DNA of mCherry was extracted from the pcDNA3-mcherry vector and introduced into the 
pcDNA3-Cdk5 vector by using the restriction sites NotI-ApaI. The coding DNA of CFP was 
extracted from the pcDNA3-CFP vector and introduced into the pcDNA3-p35 vector by 
using the restriction sites XhoI-ApaI (Fig. 10). Finally, we checked the pcDNA3-Cdk5-
mcherry and pcDNA3-p35-CFP construct for unwanted mutations by DNA sequencing.  
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The TRPV1-GFP fusion protein was created by introducing the cDNA of GFP into the 
pcDNA3-TRPV1 vector. Therefore, we introduced a new restriction site at the 3’-end of 
the TRPV1 cDNA (Fig. 11). This ApaI and the NotI restriction sites were used to insert the 
GFP cDNA in frame. 
 
Figure 10. Plasmid maps of pcDNA-Cdk5-mcherry and pcDNA-p35-CFP. pcDNA3 includes 
the cytomegalovirus (CMV) promoter for transient high-level expression in mammalian 
cells. The multiple cloning sites (MCS) include various restriction sites, which facilitates 
cloning. Moreover, the plasmid contains the ampicillin resistance gene for maintenance in 
bacteria. All remaining restriction sites of the MCS were highlighted. 
 
Figure 11. Plasmid map of TRPV1-GFP fusion protein. Plasmid includes the cDNA for 
TRPV1-GFP fusion proteins, the ampicilin resistance gene, and the multiple cloning site as 
well as the CMV promoter.  
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5.1.10 TRPV1 mutagenesis via Overlap extension PCR  
The overlap extension PCR needs two primer pairs, primer pair A for the cDNA sequence 
upstream of the targeted amino acid (e.g. T406) and primer pair B for the cDNA sequence 
downstream of the target (Higuchi et al. 1988). The reverse primer A and the forward 
primer B insert the desired mutation, while forward primer A bound 1440 bp upstream 
and the reverse primer B bound 1678 bp downstream of the T406 codon. In two 
independent PCR’s, primer pair A or B was used to generate two mutated TRPV1 cDNA 
sub-fragments: Fragment A (1440 bp) and Fragment B (1678 bp). The generated overlap 
was used to anneal fragment A and B in a second PCR. The new fragment AB was 3076 bp 
long and included the intended mutation at position T406. In order to transfer the 
mutated cDNA into the pCDNA3-TRPV1 vector the purified PCR product and the 
pCDNA-TRPV1 vector were digested with the restriction enzymes BstEII and SacII. Finally, 
the 701 bp long BstEII-SacII fragment, including the T406 mutation was ligated into the 
pCDNA3-TRPV1 vector (Fig. 12). All mutants were confirmed and checked for unwanted 
mutations by DNA sequencing. 
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Figure 12. The overlap extension PCR. The mutagenic primers (ARev and BFov) and the 
flanking primers (AFov and BRev) were used to generate fragment A and B. Both, fragment 
A and B were denatured when used as template DNA for the overlap extension PCR. The 
overlapping strands of each product hybridize and introduce the desired mutation 
(indicated by T406X). Amplification of fragment AB in the overlap extension PCR was 
driven by primers AFov and BRev. Final product fragment AB was inserted via BstEII and 
SacII restriction sites into pcDNA3 TRPV1 vector.  
5.1.11 Site-directed TRPV1 mutagenesis via pGEM-T vector cloning  
To insert site-directed mutations into the cDNA of the TRPV1 receptor we also used the T-
overhang cloning system. To this end, two different parts of the TRPV1 cDNA were 
subcloned, the first part included the TRPV1 cDNA sequence between the restriction site 
BstEII-SacII and the second part includes the TRPV1 cDNA sequence between SacII-XbaI. 
The targeted sequences were amplified in two independent PCR’s, using pcDNA3-TRPV1 
as template and BstEII forward and SacII reverse primer or SacII forward and XbaI reverse 
primer. The purified and linearized PCR products were A-tailed and ligated into the 
linearized T-tailed pGEM vector. The ligation preparation was transformed into E. coli 
bacteria to amplify and identify via blue/white screening the successfully cloned 
pGEM-TRPV1 vectors, the pGEM-TRPV1 constructs were checked by colony PCR (Fig. 13). 
Positive clones were amplified via Mini preparations.  
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In order to insert the intended mutations mutagenesis PCR’s were performed, 
pGEM-TRPV1 vectors were used as template and forward and reverse mutagenesis 
primer inserted the mutation. The long elongation time of this mutagenesis PCR led to 
the full replication of the pGEM-TRPV1 vectors. The amplification of the plasmid DNA in 
bacteria leads to DNA methylation, whereas the amplification via PCR results in 
un-methylated DNA. Therefore, the methylation specific restriction enzyme DpnI was 
used to remove the template pGEM-TRPV1 vectors. The mutated pGEM-TRPV1 and the 
pCDNA3-TRPV1 vectors were digested with either BstEII-SacII or SacII-XbaI to insert the 
intended mutation into the pcDNA3-TRPV1 vector (Fig. 14). Finally, pcDNA3-TRPV1 cDNA 
was checked for unwanted mutation by DNA sequencing. 
 
Figure 13. Construction of pGEM-T-TRPV1. TRPV1 fragments (BstEII-SacII and SacII-XbaI) 
were restricted and subcloned into pGEM-T by TA cloning.  
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Figure 14. Construction of pCDNA3-TRPV1-mutants. Mutagenesis primer AFov and BRev and 
pGEM-TRPV1-BstEII-SacII or pGEM-TRPV1- SacII-XbaI were used to introduce the desired 
mutation. DpnI restriction eliminates the template DNA and BstEII-SacII or SacII-XbaI 
restriction was used to subclone the fragments into the pcDNA3-TRPV1 vector. 
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5.2 Cell culture  
5.2.1 Cultivation of CHO and HEK293 cells  
In order to investigate the function of recombinant rat TRPV1 receptors we utilized 
immortalized Chinese hamster ovary (CHO) and human embryonic kidney (HEK) 293T 
cells. These cells are characterized by low endogenous expression of ion channels and 
their simple and reliable cultivation. Chinese hamster ovary (CHO) cells were cultured in 
MEM (PAN-Biotech, Aidenbach, Germany), whereas HEK293T cells grown in DMEM (Life 
Technologies, Carlsbad, USA). Both media were supplemented with fetal calf serum 
10% (v/v) and anti/anti 1% (v/v) (Sigma-Alderich, St. Louis, USA). Both cells lines were 
splitted into Ø 10 cm cell culture dishes (TPP, Trasadingen, Switzerland) and incubated at 
37 °C and 5% CO2. After 48 h to 72 h of growth, CHO and HEK293T cells formed adherent 
monolayers. At a confluency of 80 - 90%, the cells were washed twice with 5 ml PBS-/- 
(PBS, Sigma Life Science, Sigma Aldrich St. Louis) to remove death cells and Ca2+. In the 
following, the cells were detached by incubation in 1 ml trypsin/EDTA at 37°C for 2-3 min. 
The trypsin reaction was stopped by adding 5 ml medium. Then we transferred the cell 
suspension into 15 ml falcon tubes and centrifuged them for 4 min at 1000 rpm. The 
supernatant was discarded and the pelletized cells were re-suspended in 2 ml medium, 
300 µl of the cell suspension was diluted in 10 ml fresh media and seeded in Ø10 cm 
culture dishes. For electrophysiological experiments 50k - 100k cells were seeded on 
Ø 3 cm cell culture dishes (Sarstedt, Nümbrecht, Germany). For Ca2+-imaging or TIRF 
microscopy about 200k cells were seeded on Ø 2.5 cm glass coverslips (Menzel, 
Braunschweig, Germany). 
5.2.2 Transient transfection of CHO and HEK293 cells  
In order to introduce foreign cDNA into eukaryotic host cells, we made use of the 
Ca2+-phosphate precipitation technique (Gorman et al. 1983). The transfection mix is an 
aqueous solution containing the target cDNA, Ca2+, and the phosphate buffer HBSS. The 
cDNA was diluted in distilled water and Ca2+ as well as HBSS was added. After an 
incubation period of 15 min at room temperature, 100 µl of the transfection mix was 
added to a cell culture dish of CHO or HEK293 cells (Table 1). 12-24 hours after the 
transfection, we used the cells for electrophysiological experiments, Ca2+-imaging 
experiments, or TIRF microscopy.  
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In electrophysiological experiments we used one cell per dish, therefore the transfection 
efficacy of about 10% was sufficient. To increase the transfection efficiency for 
Ca2+-imaging and TIRF microscopy experiments we pretreated the cells with chloroqine. 
60 minutes before the transfection, we added cloroquine (0.1%), which increased the 
transfection efficiency to about 30%. The transfection of rTRPV1, CDK5-mCherry, and 
P35-CFP by means of the Ca2+-phosphate method was inefficient (about 3%), therefore, 
we made use of the Lipofectamine 2000 reagent. The Lipofectamine reagent is optimized 
for co-transfection of eukaryotic cells and increased the transfection efficiency to about 
10%. The Lipofectamin transfection mix contained 4-6 µg of the target cDNA and the 
appropriate amount of the Lipofectamine. The cDNA and the Lipofectamin reagent were 
separately diluted in equal volumes of Optimem and incubated for 10 min. In the 
following, we mixed the compounds and incubated the solution for 5 min at room 
temperature (Table 2). Finally, we added the transfection mixture to the cells and after 
incubation for 12-18 h we used the cells in electrophysiological experiments.  
 
Table 1. Ca2+-phosphate transfection mix. 
 Volume per dish Concentration 
Distilled water 36 µl  
cDNA TRPV1 5 µl 1 µg/µl 
cDNA GFP 4 µl 1 µg/µl 
Ca2+ 5 µl  
HBSS 50 µl  
 
Table 2. Lipofectamin 2000 transfection mix.   
 Volume per dish Concentration 
Optimem 100µl  
cDNA TRPV1 4 µl 1 µg/µl 
cDNA Cdk5-mCherry 6 µl 1 µg/µl 
cDNA p35-CFP 6 µl 1 µg/µl 
Lipofectamin 2000 4 µl  
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5.3 Electrophysiological experiments 
5.3.1 The patch-clamp technique  
The patch-clamp technique was developed by Erwin Neher and Bert Sakmann in order to 
investigate the function of ion channels (Neher & Sakmann 1976). For that purpose two 
electrodes were either placed in the bath solution (ground electrode) or in a glass 
micropipette (recording electrode). To close the electric circuit the micropipette is filled 
with an electrically conductive solution. The tip of the micropipette is characterized by a 
small opening (1-2 µm), which defines the diameter of the patch and the series resistance 
(4-6 MΩ). In our experiments, we used two patch configurations, the cell attached or 
whole-cell configuration. The cell-attached configuration enabled us to characterize single 
ion channels, whereas the whole-cell configuration allowed us to investigate the function 
of multiple ion channels in the plasma membrane. In order to establish the cell-attached 
configuration the tip of the micropipette was placed close to the cell membrane so that 
tip and membrane form a tight connection (Gigaseal >1 GΩ). We either recorded single-
channel events or the whole-cell configuration was established, by disrupting the cell 
membrane in the micropipette opening. The pre-amplifier or headstage is the key 
component of the patch-clamp setup. It contains the operating amplifier and the 
feedback resistor Rf. These electronic components facilitate to inject currents and to 
measure voltages with the same electrode. The cell itself acts as electronic component: 
the lipid membrane is an insulator that is surrounded by conductive saline solution, which 
is the definition for a capacitor. Additionally, the membrane has a defined resistance Rm. 
Ion channels that conduct ions through the membrane affect the capacitor and resistance 
characteristics of cell membranes (Fig. 15). The opening of ion channels lowers the 
membrane resistance and the electrochemical gradient drive the ion flux through the ion 
channel pore. These currents can be detected and amplified by the patch-clamp 
technique.  
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Figure 15. (a) Schematic and simplified circuit diagram of the patch-clamp technique, 
including the electric properties of the plasma membrane, patch pipette, and pre-
amplifier. (b) Used patch clamp configurations, for single channel characterization the cell 
attached configuration and for multiple ion channel characterization the whole-cell 
configuration.  
5.3.2 Experimental design  
Shortly before the patch-clamp experiments start, the cell culture media was replaced by 
extracellular solution. The recording chamber, including the transfected cells, was placed 
on the stage of an inverse microscope and the ground electrode was positioned in the 
bath solution. Fluorescent cells were magnified by means of a 32x objective and 10x 
oculars and identified by utilizing a xenon short-arc lamp (Osram GmbH, Munich, Germany). 
The tip of the application system was placed next to the target cell by means of a micro 
manipulator. In order to adjust and calibrate leak currents, capacity, and series resistance 
we used the integrated compensation algorithms of the amplifier. Patch-clamp recordings 
were performed at room temperature (22 °C) using a HEKA EPC10 amplifier (HEKA, 
Lambrecht, Germany) and HEKA Patchmaster software was used for data acquisition. 
5.3.3 Electrode preparation  
To prevent voltage differences between ground and recording electrode, both were 
chlorinated. Therefore, the surface of the silver wires were roughened and incubated for 
5 to 10 min in FeCl3 solution. Patch pipettes were pulled with a horizontal pipette puller 
(Zeitz Instruments, Munich, Germany) from borosilicate glass (1.17x 1.50x 100 mm) and 
had a resistance of 3-5 MΩ for whole cell or 6-8 MΩ for cell-attached configuration. 
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5.3.4 Application system   
In order to apply stimuli on the targeted cells, the tip of the application system (ALA 
Scientific Instruments, Farmigdale, USA) was placed next to the cells. The velocity of the 
outward flow was air pressure driven and adjusted to about 20 drops/min. 8 reservoirs 
that contained the different stimuli were connected via silicone tubes to the 8 in 1 mixing 
chamber and the flow was controlled by squeeze valves.  
5.3.5 Preparation of TRPV1 stimuli  
In order to induce TRPV1-mediated currents the TRPV1 specific agonist capsaicin was 
used in different concentrations (0.05, 0.1, 0.3, 1, and 3.3 µM). Therefore, capsaicin 
powder was dissolved in DMSO at a stock concentration of 33.3 mM, this stock solution 
was diluted in Ringer’s solution to the intended concentration. In order to generate the 
low pH stimulus we reduced the pH of the extracellular solution from 7.35 to 6 by adding 
HCl.  
5.3.6 Voltage-ramp and voltage-step protocols  
To measure TRPV1-mediated inward and outward currents in whole-cell configuration, 
cells were held at -60 mV and voltage ramp protocols were applied every second. Voltage 
ramps started at the holding potential of -60 mV for 100 ms, followed by a voltage step to 
-100 mV for 100 ms to record inward currents. To obtain outward currents a 500 ms long 
linear ramp segment from -100 mV to +100 mV was applied and then the ramp was held 
for 100 ms at +100 mV. The voltage ramp protocol was completed by a last step to 
-60 mV for 100 ms (Fig. 16a). In order to investigate the current-voltage relationship we 
made use of voltage-step protocols. The voltage-step protocol began with an initial 
voltage of 0 mV for 20 ms, followed by 200 ms long steps, which increased from -120 mV 
to +160 mV in 20 mV intervals. After each voltage-step the cell was held at +60 mV for 
20 ms (Fig. 16b). Voltage-ramp and voltage-step protocols were acquired with 2 kHz or 
50 kHz, additionally, a low pass Bessel filter at 2.9 kHz was used to reduce noise.  
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Figure 16. Electrophysiological protocols for measuring whole-cell currents. (a) Voltage-
ramp protocols (-100 mV to +100 mV) were used to record inward and outward currents. 
(b) Voltage-step protocols (-120 mV to +160 mV) were used to analyze the voltage 
dependence of TRPV1 receptors. 
5.3.7 Analysis of voltage-ramp and voltage-step protocols   
The average inward and outward current was automatically calculated by the 
PatchMaster software and plotted as current vs. ramp index graph. Following, the current 
vs. index graph was transformed into a current vs. time [s] graph and exported as Igor file 
for further analysis. In order to analyze the current-voltage relationship the PatchMaster 
software calculated the average current at the end of each voltage step. The current vs. 
voltage graph was exported as Igor file for further analysis (Fig. 17). The Igor Pro 
(WaveMetrics, Oregon, USA) was used to collect all necessary data for the statistical 
analysis e.g. the baseline current, the maximal induced current or the time to the half 
maximal activation. Moreover, we used the Igor Pro software to calculate the EC50 or the 
conductance G. 
 
Figure 17. Data acquisition of voltage-ramp and voltage-step protocols. (a) The 
Patchmaster software calculated the average current at -100 mV and +100 mV. (b) The 
current/voltage-relationship of TRPV1 was obtained at the end of each voltage step. The 
area between the arrows was used to calculate the average current.  
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5.3.8 Cell-attached single-channel recordings   
Single TRPV1 channels were recorded in cell-attached configuration, with a series 
resistance of >1 GΩ (Gigaseal) and leak currents below 50 pA. To equilibrate the 
membrane potential to about 0 mV the extracellular Na2+ ions were replaced by K+ ions. 
Additionally, the pipette solution contained Cs2+ and Ba2+ to block endogenous K+ 
channels. Depending on the experimental approach 0.3 µM capsaicin was added to the 
pipette solution and the pipette potential was held at -60 mV. Data were collected for 
<2 min with a sampling rate of 10 kHz and filtered with a 2.9 low pass Bessel filter.  
5.3.9 Analysis of single-channel recordings  
In order to analyze the single-channel recordings, sweeps were exported from 
PatchMaster and loaded in the TAC software (Bruxton Corporation). If necessary the 
sweep was fitted and corrected by integrated algorithms. The open probability (NPO) and 
the amplitudes of the opening events were analyzed by means of the sweep histograms 
(Fig. 18).  
 
Figure 18. Tac Software for TRPV1 single-channel analysis. (a) Exemplary event analysis of 
TRPV1 single-channel open and closing events. The green line indicates the open or 
closing of the receptor. (b) The sweep histogram (counts vs. amplitude) was used to 
calculate the open probability NPO and the amplitude.  
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Following, the open and close events were collected and exported for further analysis. 
The dwell time distribution of open and close events was calculated by means of the 
TacFit software. Finally, we calculated in excel (Microsoft) the average open probability 
(NPO). The normalized dwell time distribution and the state time constants of the open 
and closed states were fitted in Igor Pro with polynomial functions to discriminate 
between the different open and closed states. For illustration of single channel recordings 
a 1 kHz low pass filter was added. 
5.4 Fura-2 Ca2+ imaging  
The Ca2+ imaging technique was designed to investigate the calcium status of cells or 
tissue by means of fluorescent indicators. We used the ratiometric Ca2+ indicator Fura-2-
AM, which is based on the Ca2+ chelator BAPTA. The Ca2+ unbound fura-2 is exited best at 
wavelength of about 380 nm, whereas the Ca2+ bound fura-2 is excited best at 
wavelength of about 340 nm, while the emission wavelength is at about 510 nm.  
5.4.1 Experimental design  
Ca2+ imaging experiments were performed using a ZEISS live cell imaging setup, based on 
an Observer Z.1. HEK293T cells expressing the TRPV1 or TRPV1T406D were pretreated with 
the solubilizer Pluronic acid 45-120 min before the measurement and loaded with 2 µl 
Fura-2-AM (1 mM) that was diluted in 1 ml Opti-MEM. Shortly before the measurement 
the culture medium of the loaded cells was replaced by Ringer’s solution and the cells 
were placed into the recording chamber. The illumination control system was equipped 
with a UV-light source and a high speed wavelength switch (Lamda DG4, Sutter 
instruments, Novato, USA), including optical filters for the wavelengths 340 nm and 
380 nm (Carl Zeiss GmbH, Jena, Germany). The excitation light was guided trough a 
410 nm dichroic mirror and a 20x Plan-Neofluar or a 40x Fluar objective onto the cells. 
Before the emitted light was captured by the CCD MRm AxioCam, it was filtered by a 
BF510 emission band filter. Image recording and control of the microscope and Lambda 
DG4 was performed with the Zen imaging software (Carl Zeiss GmbH, Jena, Germany). 
TRPV1-mediated Ca2+ influx was induced by application of heated Ringer’s solution (about 
42°C) or 3.3 µM capsaicin.  
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The 8 in 1 inline application system with an integrated Peltier-element (Warner 
Instruments, Hamden, USA) allowed a fast change from cold to hot temperatures. 
5.4.2 Recording settings  
Fura-2 is excited by 340 nm or 380 nm of light and the ratio of the emission at 510 nm is 
directly related to the amount of intracellular Ca2+. Dependent on the fura-2 loading the 
exposure time varied between 20 and 200 ms and the binning was set to 5 x 5. The ratio 
was automatically calculated by the Zen software (Carl Zeiss GmbH, Jena, Germany). 
Regions of interest (ROI) were defined in order to analyze only the cells, and background 
correction was used to reduce noise.  
      
               
               
 
5.4.3 Ca2+ imaging data analysis   
A detailed description of the Ca2+ imaging analysis can be found in the Masterthesis of G. 
Nordmann (Nordmann 2015). By using a MATLAB algorithm an automated and unbiased 
response detection system was evolved. Additionally, the MATLAB program was able to 
evaluate the maximal induced response and the rise time (t10-90) for each cell and each 
stimulus.  
5.5 TIRF microscopy  
In order to investigate the plasma membrane expression of TRPV1 and TRPV1T406 mutants 
we used the total internal reflection fluorescence (TIRF) microscopy. The TIRF microscopy 
was developed to investigate a thin region of a specimen. Therefore, CHO cells were 
seeded on glass cover slips and were transiently transfected with GFP-tagged TRPV1WT, 
TRPV1T406A, or TRPV1T406D plasmids. By means of a Leica AF 6000LX system using a HCX PL 
APO 100x/1.47 oil objective, we monitored 24 h later the GFP fluorescence (488 nm) of 
the transfected cells. The penetration depth was set to 90 nm to gain the best signal to 
noise ratio. The GFP fluorescence was imaged in presence of Ca2+ Ringer’s solution and 
5 min after the application of a high concentration of capsaicin resulting in a final 
concentration 6.6 µM. Cells were selected and used to analyze the time course of the 
fluorescence by capturing images every 5 s.  
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5.6 Statistical analysis  
The statistical analysis of mouse behavioral tests was performed by Kulkarni et al. with 
GraphPad Prism software, version 6 (GraphPad, San Diego, CA, USA). Data are expressed 
as mean ± SEM, with n = number of animals. Statistical differences were assessed by 
unpaired t-test or by One-way ANOVA followed by Dunnett’s multiple comparisons test. 
Data of electrophysiological, Ca2+ imaging, and TRIF microscopy experiments are also 
expressed as mean ± SEM (n = number of cells). Data were analyzed and visualized by 
means of Igor Pro 6.37 (WaveMetrics, Oregon, USA), TAC x4.3.3, and TACfit (Bruxton 
Corporation,Seattle, USA), Microsoft Office (Microsoft Corporation, Redmond, USA), and 
CorelDraw X6 (Corel Corporation, Ottawa, Canada). Prior to the statistical analysis, we 
tested the data for normal distribution. The Student’s t-test was used for parametric data 
and the Wilcoxon signed-rank test for non-parametric data. The level of significance was 
set to p < 0.05. In order to calculate the EC50 or V1/2 of the capsaicin concentration-
response relationship or conductance/voltage-relationship, we used the Wavemetrics 
Igor Pro 6.37 software.  
5.7 Equations  
Hill‘s Equation:   
 
    
 
    
    
      
 
I = current, Imax = maximal current at saturating concentration, x = concentration of tested 
agonist, EC50 = the calculated concentration that elicits 50% of maximal current, and n = 
Hill coefficient. 
Sigmoidal function: 
  
           
       
      
      
 
 
G = conductance, Gmax = maximal conductance, Gmin = minimal conductance, V = applied 
voltage, V1/2 = voltage at half maximal conductance and Vslope = slope of the activation 
curve.  
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6 Results  
6.1 TRPV1 desensitization is modulated by co-expression of Cdk5 and p35  
Since Ca2+-dependent desensitization is a characteristic feature of TRPV1 receptor 
function and may have impact on the sensitivity of TRPV1 expressing nerve fibers, we set 
out to investigate the effect of Cdk5-mediated phosphorylation of TRPV1 receptors on ion 
channel function. To this end, CHO cells co-expressing TRPV1, Cdk5-mCherry and p35-CFP 
or TRPV1 and GFP were patched in whole-cell configuration and voltage-ramp protocols 
(-100 mV to +100 mV) were consecutively applied to investigate inward and outward 
currents. The co-expression of fluorescent proteins was required to visually select 
transfected CHO cells. In untransfected CHO cells the application of voltage-ramps 
induced only minor voltage-dependent currents (few endogenous voltage-dependent K+ 
ion-channels), which were not affected by the application of 3.3 µM capsaicin (Fig. 19). In 
TRPV1-expressing CHO cells, TRPV1-mediated currents were induced by perfusing the 
recorded cell with 3.3 µM capsaicin in physiological Ringer’s solution for 200 s. The 
capsaicin-induced inward and outward currents were characterized by fast activation 
kinetics as well as a strong acute desensitization in the presence of the agonist (Fig. 20a).  
 
Figure 19. Untransfected CHO cells do not show capsaicin-induced currents. Cells were 
patched in Ringer’s extracellular solution and 3.3 µM capsaicin was applied, but no 
TRPV1-mediated currents were recorded. (a) Voltage ramp-induced currents (-100 mV to 
+100 mV) in the presence or absence of 3.3 µM capsaicin. (b) Temporal course of inward 
(-100 mV) and outward (+100 mV) currents before, while and after the washout of 3.3 µM 
capsaicin (n = 5). 
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In CHO cells co-expressing TRPV1, Cdk5 and p35, the capsaicin-induced currents showed 
still fast activation kinetics, but did no longer desensitize in the presence of capsaicin 
(Fig. 20b). The desensitization ratio of TRPV1-mediated outward currents (+100 mV) was 
0.54 ± 0.04 and 0.43 ± 0.05 for inward currents (-100 mV), whereas the co-expression of 
TRPV1, Cdk5, and p35 induced a significant reduction of Ca2+-dependent desensitization, 
with ratios of 0.78 ± 0.06 at +100 mV and 0.68 ± 0.07 at -100 mV (unpaired WR-test 
p < 0.05). Since the desensitization of TRPV1 ion channels is known to depend on 
extracellular Ca2+ (Rosenbaum et al. 2004; Koplas et al. 1997), we set out to analyze the 
TRPV1 receptor desensitization in the absence of external Ca2+. The data revealed that 
the lack of external Ca2+ prevented the acute desensitization of TRPV1 receptors 
(Fig. 20c). The maximal currents recorded in TRPV1, Cdk5 and p35 co-expressing cells 
were analyzed and compared to the currents evoked in cells expressing TRPV1 only, and 
revealed a slight but significant reduction in the maximal current (unpaired WR-test 
p < 0.05) (Fig. 20d). This reduction in amplitude may reflect reduced expression levels of 
receptor proteins, since the size of the recorded cells was consistent at 25 ± 2.4 pF 
(n = 91). The acute desensitization of the receptors was analyzed by calculating the ratio 
of the maximal current and the plateau of the steady state current (Imaximal/Isteady) (Fig. 
20f). The desensitization ratio of TRPV1-mediated outward currents (+100 mV) was 
0.54 ± 0.04 and 0.43 ± 0.05 for inward currents (-100 mV), whereas the co-expression of 
TRPV1, Cdk5, and p35 resulted in ratios of 0.78 ± 0.06 at +100 mV and 0.68 ± 0.07 at 
-100 mV. The activation kinetics represented as time to half-maximal response (t50) of 
cells co-expressing TRPV1, Cdk5, and p35 was significantly increased (TRPV1: 3.2 ± 0.2 s at 
+100 mV, and 4.5 ± 0.3 s at -100 mV; TRPV1, Cdk5, p35: 4.8 ± 0.8 s at +100 mV, and 
12.6 ± 3.2 s at -100 mV; unpaired WR-test p < 0.05) (Fig. 20e). These data indicate that 
Cdk5-mediated phosphorylation of TRPV1 in CHO cells co-expressing TRPV1, Cdk5, and 
p35 has severe consequences on TRPV1 function. Therefore, we hypothesize that the 
reduced Ca2+-dependent desensitization in cells co-expressing TRPV1, Cdk5 and p35 
induces an increased receptor efficacy and promotes the development of allodynia and 
hyperalgesia in sensory neurons. 
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Figure 20. Functional characterization of capsaicin-induced TRPV1-mediated currents.  
(a) Application of 3.3 µM capsaicin in the presence of extracellular Ca2+ induced fast 
activating TRPV1-mediated currents. The Ca2+-dependent desensitization decline the 
TRPV1 currents to a steady-state. (b) Co-expression of TRPV1, Cdk5-mCherry and p35-CFP 
inhibits the Ca2+-mediated desensitization, similar to (c) the capsaicin-induced TRPV1-
mediated currents in the absence of extracellular Ca2+.  
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(d) Maximal currents, (e) time to half-maximal response represented as t50 and (f) 
desensitization as ratio Isteady / Imaximal of n = 10-36 independent measurements. Asterisk 
(*) indicates significant differences compared to the corresponding parameter recorded 
under Ca2+-containing conditions (unpaired WR-test p < 0.05). 
6.2 TRPV1, Cdk5 and p35 co-expression does not affect the capsaicin 
sensitivity 
To investigate the effect of Cdk5-mediated phosphorylation on capsaicin sensitivity of 
TRPV1, we set out to analyze the concentration/response-relationship of CHO cells 
expressing TRPV1 or TRPV1, Cdk5 and p35. Again voltage-ramp protocols (-100 mV to 
+100 mV) were used to drive outward and inward currents and various capsaicin 
concentrations (0.05, 0.1, 0.3, 1 and 3.3 µM) were successively applied in the absence of 
extracellular Ca2+. Representative recordings of CHO cells expressing (a) TRPV1 or (b) 
TRPV1, Cdk5, and p35 are shown in Figure 21 and reveal that increasing concentrations of 
capsaicin induce increasing TRPV1-mediated responses (Fig. 21). For analysis, the 
TRPV1-mediated responses were normalized to the maximal response induced by 3.3 µM 
capsaicin and the Hill equation was used to calculate EC50 values. Due to the 
voltage-dependence of TRPV1 receptors, the outward currents were increased compared 
to the inward currents, leading to different EC50 values for outward and inward signals. 
EC50 values were calculated to be 0.25 ± 0.05 µM at +100 mV and 0.63 ± 0.13 µM at 
-100 mV, whereas co-expression of TRPV1, Cdk5, and p35 resulted in EC50 values of 
0.28 ± 0.04 µM at +100 mV and 0.55 ± 0.08 µM at -100 mV. The statistical analysis of EC50 
values revealed no significant sensitization of TRPV1 ion channels due to the co-
expression of Cdk5 in CHO cells (unpaired t-test: +100 mV: p = 0.34, -100 mV: p = 0.51). In 
conclusion the concentration-response relationship of TRPV1, Cdk5, and p35 indicates 
that the sensitivity of TRPV1 to capsaicin is unaffected by Cdk5-mediated 
phosphorylation.  
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Figure 21. Capsaicin concentration/response-relationship of CHO cells co-expressing 
TRPV1 or TRPV1, Cdk5 and p35. Voltage-ramp protocols (-100 mV to +100 mV) were used 
to record TRPV1-mediated outward and inward currents in absence of extracellular Ca2+. 
(a, b) Increasing capsaicin concentrations induced increasing responses in CHO cells 
expressing TRPV1 or TRPV1, Cdk5, and p35. (c, d) Normalization to the maximal response 
and calculation of EC50 values by means of the Hill equation of inward and outward 
responses revealed that Cdk5 co-expression does not affect the TRPV1 sensitivity. EC50 
values: TRPV1 (+100 mV): 0.25 ± 0.05, (-100 mV): 0.63 ± 0.13; TRPV1, Cdk5, p35 
(+100 mV): 0.28 ± 0.04, (-100 mV): 0.55 ± 0.08; unpaired t-test (+100 mV): p = 0.34, 
(-100 mV): p = 0.51; (n = 8-10). 
6.3 TRPV1 T406 is located close to the TRP domain  
The in vivo and in vitro findings revealed that the co-expression of Cdk5 modulates the 
TRPV1 ion channel function and has severe physiological consequences. Furthermore, 
Pareek et al. could show that the TRPV1 is phosphorylated by Cdk5 at threonine-407 in 
mice, which correspond to threonine-406 in rat (Pareek et al. 2007). In order to 
investigate the functional impact of Cdk5-mediated phosphorylation on rTRPV1 at 
position T406 in detail, we made use of the high resolution cryo-microscopy structures of 
rTRPV1, which were published by Cao et al. and Liao et al. in 2013 (Liao et al. 2013; Cao et 
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al. 2013). Three different conformations of the TRPV1 are available: The apoprotein (3j5p) 
representing the closed state, the capsaicin bound (3j5r) showing an intermediated state, 
and the RTX/DkTx bound (3j5q) representing the open state (Fig. 22). The structure of the 
apoprotein reveals that the amino acid T406 is located in a flexible loop. Considering the 
conformational change in the capsaicin bound state, T406 moves to the end of an 
alpha-helix and resides in the open state near to the alpha-helix. Due to the relative 
proximity of this flexible loop to the TRP-domian, which is connected to the pore-forming 
transmembrane domain (TMD) 6, we assume that the structural changes could be part of 
the gating mechanism. Thus, we aim to characterize the functional consequences of steric 
and electric alterations at position T406. To this end T406 was replaced by the negatively 
charged amino acids Asp or Glu, the positively charged amino acids His, Lys, and Arg and 
the neutral amino acids Ile, Ala, Met, Phe, Tyr, and Pro. Since, the introduction of a 
negatively charged phosphate group at T406 led to significant functional changes, we 
were especially interested in the effect of negatively charged residues. Due to the steric 
properties of proline (helix breaking) we also replaced proline-407 by alanine to evaluate 
its functional effect. To replace the amino acids we made use of site-directed 
mutagenesis and verified each TRPV1 mutant via sequencing. By this approach we force 
the TRPV1 structure in non-native conformations, but we were able to characterize the 
effect of this specific amino acid on TRPV1 function in detail. In particular, we were 
interested in TRPV1 ion channel desensitization, sensitization, voltage-dependence, 
polymodal activation as well as single channel properties.  
 
Figure 22. TRPV1 structure in distinct conformations revealed structural changes at 
position T406. Analysis of the TRPV1 (a) apoprotein, (b) capsaicin bound and (c) RTX/DkTx 
bound revealed that T406 is located in a flexible linker close to the TRP domain including 
the TRP box. Relevant TRPV1 structures were color coded: Red transmembrane domain 
(TMD) 1-6, Purple TRP domain, Orange TRP box, and Green Cdk5 consensus site. 
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6.4 TRPV1 T406 mutagenesis modulates receptor function  
In order to investigate the effect of TRPV1T406 mutagenesis on receptor function, CHO 
cells expressing mutant receptors were challenged with 3.3 µM capsaicin for 200 s in the 
presence of extracellular Ca2+. Figure 23 shows representative capsaicin-induced outward 
and inward currents of (a) TRPV1WT, (b) TRPV1T406D, (c) TRPV1406E, (d) TRPV1T406H, (e) 
TRPV1T406K, (f) TRPV1T406R, (g) TRPV1T406I, (h) TRPV1P407A, (i) TRPV1T406A, (j) TRPV1T406M, (k) 
TRPV1T406F, (l) TRPV1T406Y, and (m) TRPV1T406P (Fig. 23). 3.3 µM capsaicin induced robust 
inward and outward currents in all TRPV1 mutants, but major differences were found in 
the activation kinetics and desensitization. The amplitudes of the TRPV1-mediated 
currents were highly variable, which is probably due to different expression rates 
(Fig. 24a). The most conspicuous effects were related to the activation kinetics of 
TRPV1T406D and TRPV1T406E, with t50 values of > 30 s demonstrating significantly slowed 
receptor kinetics (t50 at +100 mV: WT 3 ± 0.2 s, T406D 36 ± 6 s, T406E 16 ± 3 s, at -100 mV: 
WT 4 ± 0.2 s, T406D 57 ± 12 s, T406E 31 ± 5 s) (Tukey’s-test p < 0.05) (Fig. 24b). Moreover, 
the Ca2+-dependent desensitization of TRPV1WT (Isteady / Imaximal at +100 mV: 0.47 ± 0.04, at 
-100 mV: 0.39 ± 0.04) was affected by introducing at position T406 the negatively charged 
Asp or Glu, the positively charged His or Lys, as well as the bulky Pro. Analyzing the acute 
desensitization of the TRPV1T406 mutants revealed a significant reduction of Ca
2+-
dependent desensitization of CHO cells expressing TRPV1T406D (+100 mV: 0.85 ± 0.04, 
-100 mV: 0.86 ± 0.03), TRPV1T406E (+100 mV: 0.80 ± 0.04, -100 mV: 0.81 ± 0.04), 
TRPV1T406H (+100 mV: 0.76 ± 0.06), TRPV1406K (+100 mV: 0.87 ± 0.06, -100 mV: 
0.86 ± 0.04), or TRPV1T406P (+100 mV: 0.90 ± 0.02, -100 mV: 0.86 ± 0.04) (Tukey’s-test: 
p < 0.05) (Fig. 24c). In contrast, no differences were found in the other T406 mutants 
compared to TRPV1WT. Neither the activation kinetics with t50 values of 3 to 7 s nor the 
acute desensitization with Isteady / Imaximal ratios of 0.2 to 0.6 were significantly different 
from the TRPV1WT. In conclusion, these data show that position T406 is crucial for TRPV1 
function. In particular, negatively charged amino acid residues affect the activation 
kinetics and acute desensitization, but also the positively charged amino acids His and Lys, 
as well as the bulky Pro prevent the Ca2+-dependent desensitization. Interestingly, the 
exchange of P407 to alanine at the directly adjacent position had no effect on the TRPV1 
ion channel gating.  
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In summary, the reduced desensitization in T406D and T406E mutants is in line with our 
previous findings. Introduction of a negative charge at T406 (by Cdk5-mediated 
phosphorylation) inhibits the Ca2+-induced desensitization. However, the slow activation 
kinetics of TRPV1T406D and TRPV1T406E are an exclusive hallmark of the mutations, not 
found in the wild-type TRPV1 channels. Thus, we set out to investigate this aspect of 
TRPV1 activation in detail. 
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Figure 23. Representative inward and outward currents of CHO cells expressing TRPV1WT 
or TRPV1T406 mutants. Application of 3.3 µM capsaicin for 200 s induced TRPV1-mediated 
currents in Ca2+ containing extracellular Ringer’s solution to allow for ion channel 
desensitization. Inward (-100 mV) and outward (+100 mV) currents of (a) TRPV1WT, (b) 
TRPV1T406D, (c) TRPV1406E, (d) TRPV1T406H, (e) TRPV1T406K, and (f) TRPV1T406R, (g) TRPV1P406I, 
(h) TRPV1P407A, (i) TRPV1P406A, (j) TRPV1P406M, (k) TRPV1P406F, (l) TRPV1P406Y, and (m) 
TRPV1T406P.  
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The activation kinetics (t50) of TRPV1T406D and TRPV1T406E were remarkably slowed down 
and the introduction of negatively (Asp,Glu) or positively (His,Lys) charged amino acid 
residues, as well as Pro at position T406, prevented the Ca2+-induced desensitization 
(n = 7-14). 
 
Figure 24. Statistical analysis of data obtained from TRPV1T406 mutants. Data are 
presented as mean ± sem. (a) Maximal TRPV1-mediated response induced by 3.3 µM 
capsaicin. (b) Activation kinetics presented as t50 revealed that TRPV1T406D, TRPV1T406E and 
the inward current of TRPV1T406K were significantly reduced (Tukey’s-test p < 0.05). (c) 
Acute desensitization presented as ratio (Isteady / Imaximal) indicates that in TRPV1T406D, 
TRPV1T406E, TRPV1T406H, TRPV1406K or TRPV1T406P the Ca
2+-dependent desensitization was 
significantly reduced (Tukey’s-test: p < 0.05) (n = 7 - 14). 
6.5 Use-dependent activation of TRPV1T406D  
The next step was to investigate the activation kinetics of TRPV1T406D in detail. In 
particular, we were interested in the characteristics of the first and second series of 
responses induced by consecutive applications of capsaicin. Therefore, CHO cells 
expressing TRPV1WT TRPV1T406A or TRPV1T407D were recorded in the whole-cell 
configuration using Ringer’s bath solution and held for > 2 min at +100 mV. Voltage-ramp 
protocols (-100 mV to +100 mV) were used to drive inward and outward currents through 
activated TRPV1 receptors. The initial TRPV1-mediated response was evoked by the 
application of 0.3 µM or 3.3 µM capsaicin for 220 s, the second response was induced by 
the same capsaicin concentration 1 min after the capsaicin washout (Fig. 25). In CHO cells 
expressing TRPV1WT and TRPV1T406A, the first application of 0.3 µM capsaicin induced fast 
responses (WT t50, at +100 mV: 4 ± 0.4 s, at -100 mV: 6 ± 0.8 s) with maximal currents of 
WT at +100 mV: 3.5 ± 0.8 nA, at -100 mV: 1.8 ± 0.8 nA.  
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These TRPV1-mediated responses were characterized by a strong acute desensitization 
with Isteady / Imaximal ratios about 0.6 (WT, at +100 mV: 0.59 ± 0.04; at -100 mV: 
0.50 ± 0.05). CHO cells expressing TRPV1WT or TRPV1T406A were also challenged with 
3.3 µM capsaicin. The TRPV1-mediated currents had similar activation kinetics and 
desensitization ratios as the responses evoked by 0.3 µM capsaicin, but 3.3 µM capsaicin 
evoked significantly increased maximal responses (unpaired WR-test p < 0.05). CHO cells 
expressing TRPV1T406D were also held at +100 mV for > 2 min and challenged with 0.3 µM 
capsaicin, but the TRPV1-mediated currents were characterized by significantly slowed 
activation kinetics (T406D t50, at +100 mV: 63 ± 4.4 s, at -100 mV: 66 ± 6.4 s) (Tukey’s-test 
p < 0.05) and maximal amplitudes of 2.0 ± 0.6 nA at +100 mV and 0.4 ± 0.1 nA at -100 mV. 
Furthermore, the Isteady / Imaximal ratios 0.94 ± 0.02 at +100 mV and 0.94 ± 0.01 at -100 mV 
revealed that TRPV1T406D did not desensitize. Interestingly, the second application of the 
same stimulus (0.3 µM capsaicin) induced a fast TRPV1T406D-mediated response (T406D 
t50, at +100 mV: 2 ± 0.2 s, at -100 mV: 3 ± 0.4 s) with maximal amplitudes of 1.4 ± 0.5 nA 
at +100 mV, and 0.3 ± 0.2 nA at -100 mV. Comparing the 1st and 2nd maximal currents of 
TRPV1WT and TRPV1T406A revealed that the 2
nd response was significantly reduced 
(unpaired WR-test: p < 0.05). However, in TRPV1T406D we did not found a reduction of 2
nd 
maximal current, supporting the hypothesis that the T406D mutation prevents the Ca2+-
dependent desensitization. Moreover, challenging TRPV1T406D with 3.3 µM capsaicin 
evoked currents with activation kinetics and desensitization rates which were similar to 
the currents evoked by 0.3 µM capsaicin, but with increased maximal responses. 
Additionally, we analyzed the TRPV1-mediated currents of CHO cells co-expressing 
TRPV1T406D, Cdk5, and p35. Interestingly, we found no difference in activation and 
desensitization kinetics compared to cells only expressing TRPV1T406D (Fig. 26). The 1
st 
TRPV1T406D-mediated response in cells co-expressing TRPV1T406D, Cdk5, and p35 showed 
slowed activation kinetics of about 40 s at +100 mV and about 60 s at -100 mV (Fig. 26c). 
The analysis of the Isteady / Imaximal ratios revealed that the co-expression of TRPV1T406D, 
Cdk5, and p35 prevents the ion channel desensitization (Fig. 26d). These data 
demonstrate that a preceding voltage stimulus of +100 mV or the co-expression of 
TRV1T406D, Cdk5, and p35 does not affect the initial slow activation kinetics of TRPV1T406D. 
However, the priming of TRPV1T406D with capsaicin accelerates the activation kinetics of 
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TRPV1T406D receptors. In conclusion the use-dependent activation of TRPV1T406D revealed 
that a negative charge at position T406 had severe consequences on TRPV1 the activation 
and desensitization kinetics. Since we found these altered activation kinetics, we were 
interested in the molecular mechanism, which lead to this use-dependent behavior. Two 
mechanisms could play a role, the expression of TRPV1 ion channels in the plasma 
membrane or the ion channel gating mechanism. 
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Figure 25. Capsaicin-induced currents of TRPV1WT, TRPV1T406A, and TRPV1T406D in presence 
of extracellular Ca2+. CHO cells expressing TRPV1WT, TRPV1T406A or TRPV1T406D were 
challenged with 0.3 µM or 3.3 µM capsaicin after a continuous voltage stimulus of 
+100 mV for 2 min. (a, b) TRPV1-mediated currents of TRPV1WT or TRPV1T406A induced by 
0.3 µM or 3.3 µM capsaicin. The activation kinetics of the 1st and 2nd responses were fast 
(t50 < 6 s) and the responses underlie a strong Ca
2+-dependent desensitization. (c) In 
TRPV1T406D, the activation kinetics of the 1
st responses was slowed (t50 > 60 s), but the 
second response to the same stimulus was fast activating (t50 < 3 s). (d) Maximal 
responses of TRPV1WT, TRPV1T406A, and TRPV1T406D to 0.3 µM or 3.3 µM capsaicin. (e, f) 
Activation kinetics presented as time to half maximal activation (t50), reveal that the 
activation kinetics of the 1st TRPV1T406D responses were significantly slowed (p < 0.05). (g) 
Normalized desensitization of TRPV1WT, TRPV1T406A, and TRPV1T406D indicate a significant 
reduction in Ca2+-dependent desensitization of TRPV1T406D (unpaired Wilcoxon rank test: 
p < 0.05) (mean ± sem n = 4-11). 
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Figure 26. TRPV1-mediated currents of CHO cells co-expressing TRPV1T406D, Cdk5, and 
p35. (a) Representative TRPV1T406D-mediated inward (-100 mV) and outward (+100 mV) 
currents, induced by 3.3 µM capsaicin in the presence of Ca2+-containing Ringer’s 
solution. (b) maximal induced response, (c) time to half maximal activation (t50), and (d) 
normalized desensitization. Asterisk (*) indicates significant differences (paired or 
unpaired WR test respectively; p<0.05), mean ± SEM of n = 6 independent measurements 
(Jendryke et al. 2016).  
6.6 Membrane trafficking of TRPV1 and TRPV1T406 mutants  
In order to analyze the molecular mechanisms that lead to the altered activation kinetics 
of TRPV1T406D, and to address the question of whether changes in response kinetics might 
be dependent on dynamic receptor trafficking, we monitored the dynamics of membrane 
localization of directly C-terminally GFP-tagged TRPV1T406 receptor variants. 
Electrophysiological recordings of the GFP-tagged receptor variants (TRPV1WT-GFP, 
TRPV1T406D-GFP, and TRPV1T406A-GFP) proved that they were functional and showed the 
characteristic behavior of the respective untagged receptor.  
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TRPV1WT-GFP and TRPV1T406A-GFP mutants showed fast activating capsaicin-induced 
currents, and Ca2+-dependent desensitization, whereas TRPV1T406D-GFP receptors 
exhibited slow activation kinetics paralleled by reduced Ca2+-dependent desensitization 
(Fig. 27). The membrane expression of the fluorescent TRPV1 receptors was visualized by 
means of TIRF microscopy before, during and after application of a supra-maximum 
concentration of capsaicin (6.6 µM) (Fig. 28a). Fluorescence analysis of TRPV1T406-GFP 
receptors revealed that treating the cells with capsaicin does not change the fluorescence 
of TRPV1-GFP receptors in the membrane (Fig. 28b, c), indicating that the 
density/expression of TRPV1 receptors in the membrane is not altered during capsaicin 
treatment.  
 
Figure 27. TRPV1-mediated currents of TRPV1-GFP fusion proteins. Representative 
capsaicin-induced inward (-100 mV) and outward (+100 mV) currents of (a) TRPV1-GFP 
and (b) TRPV1T406D-GFP in presence of Ca
2+ Ringer’s solution (n = 3).  
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Figure 28. Trafficking of GFP-tagged TRPV1 receptors in the plasma membrane of CHO 
cells expressing GFP-tagged TRPV1 receptor variants. (a) Representative GFP fluorescence 
of CHO cells expressing TRPV1WT-GFP, TRPV1T406A-GFP or TRPV1T406D-GFP fusion proteins 
in Ringer‘s solution and after 5 min treatment with 6.6 µM capsaicin. (b) Time course of 
the GFP fluorescence of selected regions of interests (ROI)/cells TRPV1WT-GFP, 
TRPV1T406A-GFP or TRPV1T406D-GFP, image capturing was stopped during the capsaicin 
application (grey bar). (c) Mean GFP-fluorescence in Ringer’s solution (i) and 5 min after 
the application of capsaicin (ii). Mean ± SEM of n = 31-59 cells. 
6.7 T406D mutagenesis affects the voltage-dependence of TRPV1  
Interestingly, in addition to the markedly altered channel activation and desensitization 
kinetics, we observed that the TRPV1T406D-mediated outward currents (at +100 mV) after 
maximal stimulation did not reach baseline, but stayed at a higher activation level, which 
is suggestive of an altered voltage-dependence. In order to investigate the 
voltage-dependence of TRPV1T407D, voltage-induced currents were measured before, 
during the application of 3.3 µM capsaicin, and after the capsaicin washout. To avoid 
Ca2+-dependent desensitization, a Ca2+-free extracellular solution was used. TRPV1WT, 
TRPV1T407A, and TRPV1T407D cells were patched in whole-cell configuration and defined 
voltage steps (-120 mV to +160 mV) were applied.  
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TRPV1WT and TRPV1T407A recordings revealed the TRPV1 characteristic outward rectifying 
voltage-dependent currents, but hardly any currents were found in the TRPV1T407D 
recordings (Fig. 29a). However, application of 3.3 µM capsaicin induced in TRPV1WT, 
TRPV1T407A, and TRPV1T407D (after priming for 200 s) robust inward and outward currents 
with maximum currents of about 0.5 to 0.7 pA/pF at +160 mV (Fig. 29b). Finally, 
voltage-dependent currents were recorded 1 min after the washout of capsaicin 
(Fig. 29c). The currents mediated by TRPV1WT and TRPV1T407A showed neither sensitization 
nor desensitization (Fig. 29d, e), while the voltage-induced currents of TRPV1T407D 
mutants were significantly increased (paired t-test p < 0.05) (Fig. 29f). Additionally, 
voltage-induced currents of TRPV1T406D were measured 2, 3, and 5 min after the capsaicin 
washout (Fig. 30). To further evaluate the voltage-dependence, the conductance G was 
calculated and the ratio of G/Gmax (Gmax = maximal conductance) was plotted against the 
voltage (Fig. 31). In this conductance/voltage relationship, the data revealed changes in 
the voltage-dependence of TRPV1 channels. Therefore, the data were fitted by means of 
a sigmoidal fit and the V1/2 (V1/2 = voltage at half maximal activation) was calculated 
(Fig. 31a, b, c). Analyzing the conductance of TRPV1WT, TRPV1T406A, and TRPV1T406D 
receptors revealed that the application of 3.3 µM capsaicin led not only to an increase in 
conductance, but also to a marked reduction in V1/2 from about 120 mV to about -20 mV. 
However, in contrast to TRPV1WT and TRPV1T406A, where the conductance recovered after 
washout, TRPV1T406D persisted in a high conducting state with a significantly reduced (left 
shifted) V1/2 from about +110 to about +69 mV after the washout of 3.3 µM capsaicin 
(paired WR-test p<0.05) (Fig. 31d). This significant reduction of V1/2 was also persistent 2, 
3, and 5 min after the capsaicin-induced activation (Fig. 31e, f), which indicates that the 
priming of TRPV1T406D with capsaicin has severe consequences on the voltage-
dependence of the ion channel. In conclusion, these data demonstrate that the mutation 
of T406 to a negatively charged aspartic acid (T406D) strongly affects the voltage-
dependence of TRPV1 receptors, which also indicates that the use-dependent behavior is 
related to an altered ion channel gating. 
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Figure 29. T406 mutagenesis affects the voltage-dependence of TRPV1 receptors. 
Transiently transfected CHO cells were measured by voltage step protocols with 
depolarizing pulses from -120 mV to +160 mV. (a) In Ca2+-free Ringer’s solution, 
voltage-dependent currents were recorded in TRPV1WT and TRPV1T406A, but not in 
TRPV1T406D. (b) Application of 3.3 µM capsaicin induced robust voltage-dependent 
currents in CHO cells expressing TRPV1WT, TRPV1T406A or TRPV1T406D. (c) 
Voltage-dependent currents evoked one minute after washout of capsaicin, revealed an 
increased voltage-dependence of TRPV1T406D, whereas the voltage-induced currents of 
TRPV1WT, TRPV1T406A recover to the same level as under Ringer conditions. Normalized 
voltage-dependence of (d) TRPV1WT, (e) TRPV1T406A, and (f) TRPV1T406D. Asterisk (*) 
indicates significantly increased outward currents of TRPV1T406D after priming with 3.3 µM 
capsaicin (paired WR-test p < 0.05) (n = 6-7). 
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Figure 30. Voltage-dependence of TRPV1T406D-mediated currents 2, 3, and 5 min after the 
capsaicin washout. Same experimental setup as in the previous step protocol 
measurements n = 4. 
 
 
Figure 31. Conductance/voltage analysis of TRPV1WT, TRPV1T406A, and TRPV1T406D. The 
normalized conductance (G/Gmax) was fitted with a sigmoidal equation to analyze V1/2.  
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Representative conductance/voltage-relationships of (a) TRPV1WT, (b) TRPV1T406A and (c) 
TRPV1T406D under Ringer’s solution, 3.3 µM capsaicin and 1 min after the capsaicin 
washout. (d) Statistical analysis of V1/2 of TRPV1T406D revealed a significant decrease after 
the priming with 3.3 µM capsaicin (unpaired t-test p < 0.05). (e,f) Analysis of voltage-
induced currents 1, 2, 3 and 5 min after the capsaicin washout revealed that V1/2 of 
TRPV1T406D was significantly reduced even 5 min after the washout of capsaicin (paired 
t-test p < 0.05).  
6.8 TRPV1T406 mutation alters the capsaicin sensitivity  
In order to investigate the capsaicin sensitivity of the different TRPV1 receptor mutants, 
we analyzed the concentration/response-relationship. Therefore, various capsaicin 
concentrations (0.05, 0.1, 0.3, 1, and 3.3 µM) were applied to stimulate TRPV1 receptors. 
TRPV1 receptor desensitization was prevented by using a Ca2+-free extracellular solution. 
Due to the use-dependent activation of TRPV1T407D the capsaicin concentration/response-
relationship was analyzed in two consecutive sets of application (before and after priming 
with 3.3 µM capsaicin). To analyze the EC50 values the responses were normalized to the 
maximal induced response and the concentration-response curves were approximated by 
the Hill-equation. In TRPV1WT, TRPV1T406R, and most of the neutral TRPV1T406 mutants 
(expect T406P), we found no changes between the EC50 values of the 1
st and 2nd capsaicin 
series (Fig. 32) (Table 3). Introduction of proline or the positively charged residues 
histidine or lysine induced a left shift of the 2nd concentration-response curves, with 
decreased EC50 values (Fig. 32d, e, m) (Table 3). The low responsiveness of TRPV1T406D and 
TRPV1T406E in the first set of capsaicin application prevented an accurate approximation to 
the Hill-curves. The second set of capsaicin application after priming with 3.3 µM 
capsaicin induced robust responses (Fig. 32b, c). The sensitivity of TRPV1T406D or 
TRPV1T406E was significantly increased after priming the receptors with 3.3 µM capsaicin, 
compared to TRPV1WT (Tukey’s-test p < 0.05). EC50 values at -100 mV were for TRPV1WT: 
1st 0.63 ± 0.13 µM, 2nd 0.66 ± 0.14 µM; TRPV1T406D: 2
nd 0.26 ± 0.03 µM and at +100 mM: 
TRPV1WT: 1
st 0.25 ± 0.05 µM, 2nd 0.28 ± 0.06 µM; TRPV1T406D: 2
nd 0.11 ± 0.01 µM (Table 3). 
Different EC50 values for inward and outward currents were based on the 
voltage-dependence of TRPV1 ion channels, demonstrating that positive potentials 
(+100 mV) increased the TRPV1 receptor sensitivity to capsaicin (Gunthorpe et al. 2000).  
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The altered capsaicin sensitivity of TRPV1T406 mutants, especially the sensitization of 
TRPV1T406D and TRPV1T406E during the second application series supports the hypothesis 
that amino acid properties such as charge or bulkiness had severe consequences on 
TRPV1 ion channel function.  
 
Results 
59 
 
 
Results 
60 
 
 
 
Results 
61 
 
 
Figure 32. Capsaicin concentration/response-relationship of TRPV1WT and TRPV1 mutants. 
Based on the use-dependent activation of TRPV1T406D and TRPV1T406E the TRPV1 
expressing cells were challenged twice with increasing capsaicin concentrations (0.05 to 
3.3 µM). Ca2+-free extracellular solution was used to avoid ion channel desensitization. 
The first and second application series of capsaicin induced in (a) TRPV1WT, (f) TRPV1T406R, 
(g) TRPV1T406I, (h) TRPV1P407A, (i) TRPV1T406A, (j) TRPV1T406M, (k) TRPV1T406F, and (l) 
TRPV1T406Y similar responses. The low responsiveness of (b) TRPV1T406D and (c) TRPV1T406E 
in the first series of applications did not allow for an accurate estimation of the EC50. 
Priming the receptors with 3.3 µM capsaicin increased the sensitivity. Analysis of the 
positively charged mutants (d) TRPV1T406H, (e) TRPV1T406K, as well as (m) TRPV1T406P 
revealed a left-shift in the second concentration/response-relationship. Data were 
collected form n = 5 - 10 independent measurements.  
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Table 3. EC50 values of TRPV1WT and TRPV1 mutants. Left panel: 1
st and 2nd EC50 ± SEM at 
-100 mV, right panel: 1st and 2nd EC50 ± SEM at +100 mV. Due to the weak responses of 
TRPV1T406D and TRPV1T406E in the first set of applications, EC50 values could not be 
calculated. Asterisk (*) indicates significantly reduced EC50 values of TRPV1T406D and 
TRPV1T406E after priming with 3.3 µM capsaicin compared to the 2
nd EC50 value of TRPV1WT 
(Tukey-test  p < 0.05) (n = 5-10). 
6.9 TRPV1 T407 mutagenesis affects the proton activation  
The TRPV1 receptor can be activated by various stimuli such as voltage, capsaicin, heat or 
protons. In contrast to the intracellularly located capsaicin binding site, the proton 
binding site is located at the extracellular part of the pore-loop and may trigger a 
different gating mechanism. Thus, we wanted to investigate the sensitivity of TRPV1WT 
and TRPV1 mutants to low pH. For this purpose, CHO cells expressing the respective 
receptors were challenged with two consecutive sets of applications of pH 6, followed by 
0.3 µM and 3.3 µM capsaicin in the absence of extracellular Ca2+. TRPV1WT and TRPV1T406 
mutants with positively charged residues as well as most of the neutral T406 mutants 
responded similar to pH 6, 0.3 µM and 3.3 µM capsaicin in the first and second series of 
application (Fig. 33a, d-l). In contrast, the negatively charged TRPV1T406D or TRPV1T406E, as 
well as TRPV1T406P did not respond (or only weakly) to the first application of pH 6 and 
0.3 µM capsaicin. However, after priming with 3.3 µM capsaicin, they gained full 
responsiveness to low pH and 0.3 µM capsaicin (Fig. 33b, c, m). To describe the response 
characteristics, ratios were calculated between the amplitudes of 1st and 2nd responses. 
Ratios of >1 represent ion channel desensitization, whereas ratios of <1 indicates ion 
channel sensitization.  
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In TRPV1WT, and TRPV1T406 mutants with positively charged as well as neutral residues 
(expect proline) we found ratios of 0.8 - 1.2 for pH 6, 0.3 µM and 3.3 µM capsaicin. These 
data indicate that the receptors do not sensitize or desensitize after maximal stimulation 
with 3.3 µM capsaicin. The ratios of TRPV1T406P (0.49 - 0.64), revealed a slight but 
significant sensitization to pH 6 and 0.3 µM capsaicin (Tukey’s test p < 0.05). TRPV1T406D 
and TRPV1T406E revealed ratios of <0.2 for pH 6 and 0.3 µM capsaicin, indicating a strong 
sensitization after priming with 3.3 µM capsaicin (Tukey’s test p < 0.05) (Fig. 34a, b). 
Furthermore, we found increased ratios of the 3.3 µM capsaicin-induced response 
indicating an increased voltage-dependence of TRPV1T406D/E mutants (Fig. 34c). In 
summary, these data reveal that TRPV1T406 mutagenesis not only affects the capsaicin, but 
also the pH 6-mediated activation of TRPV1, supporting the hypothesis that the mutation 
of T406 modulates the TRPV1 ion channel gating mechanism.  
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Figure 33. Proton and capsaicin mediated activation of TRPV1WT and TRPV1 mutants. 
TRPV1-mediated currents were evoked by application of Ca2+-free extracellular solution at 
pH 6, followed by the application of 0.3 µM and 3.3 µM capsaicin. Left panel: 
representative recordings of voltage-ramp induced inward and outward currents. Right 
panel: Ratios of 1st and 2nd response to the same stimuli, values >1 indicates 
desensitization and values <1 indicates sensitization after priming (n = 5-15). 
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Figure 34. Statistical analysis of pH 6, 0.3 µM or 3.3 µM capsaicin evoked responses. After 
priming with 3.3 µM capsaicin TRPV1T406D, TRPV1T406E, and TRPV1T406P were significantly 
sensitized to (a) pH 6 and (b) 0.3 µM capsaicin (Tukey’s test p < 0.05). (c) The ratios of the 
outward current of TRPV1T406D and TRPV1T406E, induced by 3.3 µM capsaicin, were 
significantly increased, indicating an increased voltage-dependence after priming. Ratios 
of peak amplitudes of n = 5-15 independent measurements were presented as 
mean ± sem (Tukey’s test: p < 0.05). 
6.10 Heat activation of TRPV1T406D in Ca
2+ imaging experiments  
To further investigate the polymodal activation of TRPV1 receptor mutants, we set out for 
another experimental approach. Together with G. Nordmann we performed the following 
Fura-2 Ca2+ imaging experiments (Nordmann 2015). The aim was to investigate the heat 
sensitivity of TRPV1 receptor mutants by utilizing HEK293T cells expressing TRPV1WT or 
TRPV1T407D. The TRPV1 ion channel is highly permeable to Ca
2+, therefore we induce 
TRPV1-mediated Ca2+ influxes by challenging cells with capsaicin (3.3 µM), or by perfusing 
the recording chamber with physiological Ringer’s solution heated up to 42 °C. 
Representative Ca2+ imaging measurements of HEK293T cells expressing TRPV1WT or 
TRPV1T406D are presented in Figure 35. Cells were challenged by heating up the bath 
solution to 42 °C for at least 2 min. After a recovery phase of about 5 min, the maximal 
TRPV1-mediated Ca2+ influx was induced by the application of 3.3 µM capsaicin at room 
temperature (24 °C). A second heat activation was performed 15 min after the washout of 
3.3 µM capsaicin (Fig. 35). In order to quantify the sensitization of TRPV1 receptors, the 
first and second heat responses were normalized to the peak amplitude of the capsaicin-
induced responses. The analysis revealed no differences between the first and second 
heat-induced responses of TRPV1WT, but we found significantly increased amplitudes of 
the second heat-induced responses in TRPV1T406D receptors (paired t-test p < 0.05) 
(Fig. 35e). Furthermore, recordings of TRPV1WT receptors revealed similar activation 
kinetics (t10-90) of first and second responses (about 40 s), whereas the responses of 
TRPV1T406D expressing cells showed accelerated activation kinetics in the second series of 
applications (paired t-test p < 0.05) (Fig. 35f). The Ca2+ imaging data revealed that 
TRPV1T406D mutants were less sensitive to the first heat stimuli, but gained full 
responsiveness after priming with 3.3 µM capsaicin. These observations are in line with 
Results 
69 
 
our previous patch-clamp recordings and support the hypothesis that TRPV1T406D affects 
the gating mechanism of TRPV1.  
 
Figure 35. Fura-2 Ca2+ imaging of HEK293T cells expressing TRPV1WT or TRPV1T406D. 
Representative ratio images and time courses of (a, b) TRPV1WT and (c, d) TRPV1T406D 
measurements. The TRPV1-mediated influx of Ca2+ was induced by challenging cells with 
42 °C, 3.3 µM Capsaicin and a 2nd heat application. (e) First and second responses to heat 
were normalized to the responses induced by 3.3 µM capsaicin. Statistical analysis 
revealed that the first responses of TRPV1T406D were significantly smaller, but gained full 
responsiveness after priming with 3.3 µM capsaicin (paired t-test, p < 0.05). (f) The 
activation kinetics (t10-90) of TRPV1WT were similar in first and second heat induced 
responses (1st 42 ± 1.6 s, 2nd 46 ± 1.7 s), but after the maximum activation the rise time of 
the second responses of TRPV1T406D were significantly accelerated (1
st 51 ± 2.2 s, 2nd 31 ± 
0.8 s) (paired t-test p < 0.05) (n = 131-135) (Nordmann 2015). 
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6.11 TRPV1 single-channel characteristics are altered in T406D mutants  
In order to investigate the function of the TRPV1T407D mutant on the single-channel level, 
we set out to analyze several biophysical single-channel properties such as amplitude, 
open probability and dwell-time distribution. Therefore, the opening and closing events 
of TRPV1WT and TRPV1T407D channels were recorded for periods of 2 min in the 
cell-attached configuration. A high [K+] (140 mM) extracellular solution was used to 
equalize the cell membrane potential to 0 mV and 10 mM BaCl2 was added to the patch 
pipette solution to block endogenous K+ ion channels. Figure 36 shows representative 
single-channel recordings and event distribution histograms of TRPV1WT and TRPV1T406D. 
In general, the single-channel amplitudes depend on the driving force (electrochemical 
gradient) and the ion channel pore characteristics. Based on an approximated membrane 
potential of 0 mV and a pipette potential of -60 mV, the TRPV1 single-channel amplitudes 
were measured to be 5 to 8 pA. Interestingly, the open events of TRPV1T406D before 
priming did not show constant amplitudes, but tend to decrease from an initial high to a 
lower plateau conductance state (Fig. 36). This behavior indicates a dynamic process 
within the pore, leading to alteration of conductance/permeability during gating of 
TRPV1T406D. However, the mechanism behind this observation is not clear at the moment. 
In order to analyze the open probability (NPO) of TRPV1WT and TRPV1T406D, ion channel 
event distribution histograms were extracted from the data. The average NPO was found 
to be 16.5 ± 5.1% in TRPV1WT and 1.5± 1.2% in TRPV1T407D recordings. Adding 0.3 µM 
capsaicin to the pipette solution increased the average open probability of TRPV1WT ion 
channels to 60.6 ± 8.2%, whereas in TRPV1T407D recordings the NPO increased only to 
4.9 ± 2%, demonstrating the low activity of TRPV1T406D under these conditions. Pre-
treating TRPV1T407D expressing cells for two minutes with 3.3 µM capsaicin led to priming 
of the receptor and increased the open probability to 88.8 ± 5% when 0.3 µM capsaicin 
was added to the pipette solution (after washout of the external capsaicin), again 
reflecting the use-dependent activation of TRPV1T406D.  
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The statistical analysis of the open and closed states of TRPV1WT and TRPV1T406D receptors 
(at +60 mV and in the presence of 0.3 µM capsaicin) revealed that TRPV1T406D receptors 
spent significantly less time in the open state (unpaired WR-test p < 0.05), but priming 
TRPV1T406D receptors with 3.3 µM capsaicin shifted the open probability to about 90%, 
similar to what is obtained in TRPV1WT (Fig. 37). These findings were in line with the 
previous whole-cell recordings, indicating that the use-dependent activation of 
TRPV1T406D might be based on the engagement of different confirmations.  
In order to determine the state time constants of the open and closed states, the 
recorded single-channel events were further analyzed by calculating the open and close 
dwell-time distribution. Thus the root square of the frequency was plotted against the 
natural logarithm of time and fitted with polynomial functions. That enabled us to 
discriminate between the different open and closed states of the receptor and to analyze 
the gating mechanisms of the TRPV1 ion channel protein. Figure 38 shows representative 
dwell-time histograms for the activity of TRPV1WT and TRPV1T406D. Similar to Studer and 
McNaughton we were able to identify three open states (O1-O3) and four closed states 
(C1-C4) (Studer & McNaughton 2010). The time constants of the open states as well as 
the relative contribution of the O1-O3 states seem to slightly vary with different 
experimental conditions (0.3 µM, with/without priming with 3.3 µM capsaicin), the open 
states were not significantly different between TRPV1T406D mutant and TRPV1WT. 
However, the detailed analysis of the closed states C1-C4 revealed an (compared to 
TRPV1WT) increasing long time constants C4 in the TRPV1T406D mutant, which is markedly 
reduced in both, time and relative contribution in the presence of 0.3 µM capsaicin after 
priming. However, closed states of TRPV1WT are only slightly modulated by capsaicin. 
Therefore, the analysis of the gating properties point to the involvement of closed states 
modulation of TRPV1T406D, resulting in the observed use-dependent behavior.  
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Figure 36. T406D mutagenesis affects the TRPV1 single channel characteristics. Single 
channel events were recorded in cell attached configuration at -60mV pipette potential 
for <2 min. A high [K+] (140 mM) bath solution was used to equalize the membrane 
potential. The pipette solution contains Cs+ and Ba2+ to block endogenous K+ channels. 
Representative single channel traces and exemplary open probability of TRPV1WT and 
TRPV1T406D at (a, b) -60 mV, (c, d) -60 mV and 0.3 µM capsaicin, and (e, f) -60 mV, 0.3 µM 
capsaicin and priming with 3.3 µM capsaicin for 2 min. Interestingly, the current levels of 
TRPV1T406D were not constant, the conductance shifts from an initial high to lower state.  
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Figure 37. Open probability (NPO) and single channel amplitude of TRPV1WT and 
TRPV1T406D. (a) The NPO of spontaneous and capsaicin (0.3 µM)-induced channel opening 
is significantly lower in TRPV1T406D than in TRPV1WT (p < 0.05). The open probabilities of 
TRPV1T406D and TRPV1WT become equal after priming with 3.3 µM capsaicin. (b) TRPV1WT 
and TRPV1T406D single channel amplitudes in cell-attached configuration at an 
approximate membrane potential of 0 and a pipette potential of -60 mV. Mean ± sem of 
n = 3-6 independent measurements (unpaired WR-test p < 0.05).  
 
 
Results 
74 
 
 
Figure 38. Dwell-time distribution analysis of TRPV1WT and TRPV1T406D single-channel 
recordings. Representative open and closed dwell-time histograms of (a) TRPV1WT and (b) 
TRPV1T406D at -60 mV (i), -60 mV + 0.3 µM capsaicin (ii), and -60 mV + 0.3 µM capsaicin 
after priming with 3.3 µM capsaicin (iii). The polymodal fit of TRPV1WT and TRPV1T406D 
dwell-time distributions revealed 3 open states (O1, O2, and O3) as well as 4 closed states 
(C1, C2, C3, and C4), marked as *. (c, d) The open state time constants and their relative 
contribution revealed no significant differences between TRPV1WT and TRPV1T406D. 
However, the closed state C4 was significantly (*) higher under Ringer’s condition, 
compared to the corresponding TRPV1WT C4 and the TRPV1T406D C4 after priming with 
3.3 µM capsaicin (unpaired WR-test p < 0.05) (n = 3-10) (Jendryke et al. 2016). 
6.12 What is the molecular mechanism that alters the ion channel gaiting?  
The in vivo results revealed that the TRPV1-mediated responses to capsaicin and heat 
were modulated by the co-expression of Cdk5. Increasing the Cdk5 expression level in 
sensory neurons induces TRPV1-mediated hyperalgesia and allodynia, while a Cdk5 CoKo 
or a p35KO led to hypoalgesia. The in vitro experiments revealed that the co-expression 
of TRPV1, Cdk5, and p35 prevents the Ca2+ induced desensitization of TRPV1WT. 
Mutagenesis of the Cdk5 phosphorylation site T406 enabled us to characterize the impact 
of that specific residue on TRPV1 function in detail. The exchange of T406 to the 
negatively charged aspartic acid had severe consequences for TRPV1 ion channel 
function. We could demonstrate that several biophysical properties were modulated in 
TRPV1T406D. The activation kinetics were slowed, the voltage-dependence, the sensitivity 
to capsaicin, low pH or heat were modified and the Ca2+-dependent desensitization was 
prevented. Finally, we found in single-channel experiments that the closed state C4 of the 
TRPV1T406D mutant is prolonged and is therefore the molecular parameter responsible for 
the modified TRPV1T406D function.  
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The question now is:  
What is the structural/functional relationship that connects the Cdk5-dependent 
phosphorylation at position T406 to the TRPV1 gating mechanism? 
In order to investigate position T406 with regard to the ion channel pore and gating 
mechanism, we made use of the high resolution structure of the TRPV1 and analyzed the 
3D structure in cooperation with C. Ziegler (LS Biophysik, UR) (Fig. 39). The analysis 
showed that the membrane proximal domain (MPD), including T406, is relatively close to 
the TRP-domain, which is directly connected to the pore-forming transmembrane 
domain 6. Furthermore, we noticed that the conformational changes between the close 
and open state, comprise altered distances between the amino acid residues Y401, R499, 
and D707. We focused on these amino acids based on the assumption that they may 
participate in the gating process and might be involved in stabilizing the conformation of 
the respective states. Y401 is close to T406 and part of the flexible loop, R499 is located in 
the intracellular loop between TMD 2 and TMD 3 and close to the PKA phosphorylation 
site S501, and D707 is part of the TRP domain. Analyzing the distance between Y401 and 
D707 revealed that the distance of 3.1 Å in the closed state shortens to 2.6 Å in the 
open/intermediate state, allowing direct interaction of Y401 and D707 via hydrogen 
bridges. Assuming that the TRP-domain directly affects the ion channel gating by 
modulating the pore forming TMD 6, it may be possible that TRP-domain adjacent 
structures affect the ion channel gating by interacting with the TRP-domain. To 
investigate this hypothetical transition pathway, we generated together with M. Schladt 
several alanine mutants and performed a detailed electrophysiological characterization. 
We generated the following TRPV1 single mutants (Y401A, R499A, or D707A), and double 
mutant receptors (Y401A-T406D, Y401A-D707A, and T406D-D707A) (Schladt 2015). To 
investigate whether these amino acids are involved in the transition-pathway (TP) and 
influence TRPV1 gating properties, the various receptor mutants were functionally 
characterized in patch-clamp experiments regarding desensitization, voltage-dependence, 
and sensitivity to capsaicin or protons. 
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Figure 39. High resolution cryo-EM structures of TRPV1 (a) Apoprotein, (b) capsaicin 
bound and (c) RTX/DkTx bound. D707 and Y401 are close proximity in the closed and 
intermediate state, with distances of 3.1 Å (closed state) and 2.6 Å (intermediate state), 
which allow direct interactions via hydrogen bridges. R499 resides next to D707 and Y401, 
but due to distances larger than 2.6 Å, direct interactions are considered unlikely to 
occur. In the open state, the distance between D707 and Y401 is increased rendering 
direct interactions impossible. Relevant TRPV1 structures were color coded: Red 
transmembrane domain (TMD) 1-6, Purple TRP domain, Orange TRP box, Green Cdk5 
consensus site, and Blue Transition pathway mutants. 
6.13 Desensitization of transition pathway mutants  
In order to investigate activation and desensitization kinetics of the transition pathway 
mutants, CHO cells expressing the TRPV1 double-mutants were recorded in whole-cell 
configuration in the presence of extracellular Ca2+. Inward and outward currents were 
induced by the consecutive application of voltage-ramps (-100 mV to +100 mV) and 
TRPV1-mediated responses were induced by 3.3 µM capsaicin (Fig. 40). For analysis of ion 
channel desensitization, ratios of Imaximal/Isteady were calculated and the activation kinetics 
was presented as time to half maximal response (t50). The stimulation of TRPV1WT with 
3.3 µM capsaicin induced fast TRPV1-mediated currents, characterized by a strong acute 
desensitization. In contrast, the transition pathway mutants lacked a Ca2+-dependent 
desensitization. The maximal responses were presented in Figure 41a. The mean ± sem 
values indicate a high variability, which might be based on different expression rates. 
Analysis of the t50 values revealed that mutagenesis in the structures adjacent to the 
TRP-domain strongly reduced the activation kinetics of the response to the first 
application of capsaicin (Fig. 41b). In TRPV1WT and TRPV1D707A we found t50 values of 5 to 
10 s for outward and inward currents, but the other TP-mutants showed significantly 
slowed activation kinetics with t50 values of 20 to 60 s at +100 mV and 30 to 70 s at 
-100 mV (Tukey’s test p < 0.05).  
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Furthermore, we found that the Ca2+-induced desensitization (Isteady/Imaximal) was 
prevented in the transition pathway mutants (Tukey’s test p < 0.05) (Fig. 41c). Based on 
these data it can be concluded that TRP-domain residues (D707) as well as adjacent 
residues, such as Y401 and R499 modulate the activation kinetics and desensitization of 
TRPV1 ion channels.  
 
Figure 40. Desensitization of TRPV1 transition pathway mutants. TRPV1-mediated 
currents were evoked by applying 3.3 µM capsaicin in the presence of extracellular Ca2+. 
Ca2+-mediated desensitization was prevented in all TRPV1 transition pathway mutants. 
Additionally, the activation kinetics of TRPV1 mutants (a) Y401A, (b) Y401A-T406D, (d) 
T406D-D707A, and (f) R499A was reduced (n = 5–8). 
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Figure 41. Analysis of TP pathway mutants. (a) TRPV1-mediated responses induced by 
3.3 µM capsaicin were variable, but not significantly different (Tukey’s-test n.s.). 
(b) Compared to the TRPV1WT, activation kinetics of Y401A, Y401A-T406D, T406D-D707A, 
and R499A were significantly slowed (Tukey’s-test p < 0.05). (c) The Ca2+-dependent 
desensitization was prevented in TRPV1 transition pathway mutants (Tukey’s-
test:p < 0.05). Data is presented as mean ± sem of n = 5-8 independent measurements. 
6.14 TP-mutant capsaicin concentration/response-relationship  
Next we were interested in the capsaicin sensitivity of the transition pathway mutants. 
Therefore, CHO cells expressing the mutant TRPV1 receptors were challenged with 
various capsaicin concentrations (0.05 µM to 3.3 µM) in the absence of extracellular Ca2+. 
As in the TRPV1T406D experiments, the concentration/response-relationship of the 
TP-mutants were analyzed before and after priming with 3.3 µM capsaicin (Fig. 42). In 
TRPV1WT measurements, the first and second concentration/response-relationship 
revealed the same response pattern with EC50 values of 1
st 0.34 ± 0.07, 2nd 0.39 ± 0.12 µM 
at +100 mV; 1st 0.65 ± 0.14, 2nd 0.68 ± 0.14 µM at -100 mV, and similar Hill curves and EC50 
values were determined for the TRPV1D707A mutant (Table 4). In TRPV1 Y401A, 
Y401A-T406D, T406D-D707A, and R499A mutants, the first application series of capsaicin 
evoked no or only weak TRPV1-mediated currents, which did not allow the calculation of 
EC50 values. After priming with 3.3 µM capsaicin, these TRPV1 TP-mutants gained full 
responsiveness and obtained EC50 values which were similar to those of TRPV1WT 
(Table 4). In the TRPV1 double-mutants Y401A-T406D and T406D-D707A, the first 
application series of capsaicin evoked no TRPV1-mediated currents.  
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However, in the second series of applications, capsaicin induced responses with 
significantly reduced EC50 values 0.09 ± 0.01 µM at +100 mV (Tukey’s test: p < 0.05). These 
data show that the capsaicin sensitivity of TRPV1 receptors were unaffected in D707A 
mutants, but mutagenesis of adjacent residues such as Y401A, R499A and Y401A-D707A 
affects the capsaicin sensitivity before priming. Furthermore, data obtained from the 
double-mutants Y401A-T406D and T406D-D707A revealed that the aspartate at position 
T406 contributes to sensitization of the TRPV1 receptor to capsaicin.  
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Figure 42. Capsaicin concentration/response-relationship of TRPV1 transition pathway 
mutants. Left panel: Representative inward and outward currents of TRPV1WT or TP 
mutants induced by increasing capsaicin concentrations (0.05 to 3.3 µM). Right panel: 
Corresponding normalized responses and Hill curves for the calculation of the EC50 values 
for 1st and 2nd inward and outward responses.  
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Weak or no responsiveness to capsaicin in some TP mutants prevents the calculation of 
EC50 values for the first application series n = 4-8. 
 
Table 4. EC50 values of TP mutants. In the most of the TP mutants, the weak 
responsiveness to low concentrations of capsaicin did not allow the calculation of EC50 
values. Interestingly, outward currents mediated by Y401A-T406D and T406D-D707A 
TRPV1 receptors during the 2nd application series showed a significantly (*) increased 
capsaicin sensitivity (Tukey’s-test p < 0.05; n = 4-8). 
6.15 Voltage-dependence of transition pathway mutants  
Since the voltage dependence of TRPV1T406D is enhanced by priming the receptor with 
3.3 µM capsaicin, we wanted to test whether the voltage-dependence of the transition 
pathway mutants is also subject to modulation. To this end, transiently transfected CHO 
cells were electrophysiologically characterized in the whole-cell configuration. In absence 
of extracellular Ca2+, voltage steps (-120 to +160 mV) were applied before, during, and 
60 s after washout of 3.3 µM capsaicin. Analyzing the voltage-dependence of TRPV1WT 
and TP-mutants revealed no significant differences (Fig. 43). In Ca2+-free Ringer’s solution, 
most of the mutants showed voltage-induced currents (0.1-0.3 nA/pF), which were 
increased by the application of 3.3 µM capsaicin (0.4-1 nA/pF). The current densities in 
the TRPV1 double mutants Y401A-T406D and T406D-D707A were too small 
(40-60 pA/pF). The conductance G was calculated and normalized to Gmax, in order to 
estimate V1/2 by means of a sigmoidal fit. The analysis of the conductance revealed that 
the TP-mutants did not show an altered voltage-dependence before and after the full 
activation of the TRPV1 receptor protein.  
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Under Ringer’s condition, we found in all TP mutants a V1/2 of +100 to +120 mV, which 
was reduced to -20 to -60 mV during capsaicin application. Interestingly, the Y401A-
T406D and T406D-D707A mutants also showed no altered voltage-dependence after the 
washout of capsaicin. However, the TRPV1T406D mutant showed an increased 
voltage-dependence after the capsaicin washout, but the TP mutants did not showed an 
altered voltage-dependence after the washout of 3.3 µM capsaicin. Therefore, we 
conclude that the transition pathway mutants did not reproduce the altered voltage 
dependence of the TRPV1T406D mutant.  
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Figure 43. Voltage-dependence of TRPV1 transition pathway mutants. IV-relationships 
were measured in Ca2+-free Ringer’s solution using voltage-step protocols 
(-120 to 160 mV), before, during, and 1 min after washout of 3.3 µM capsaicin. n = 5-7 
6.16 Low pH activation of TRPV1 transition pathway mutants  
Finally, we were interested in the activation of TP mutants by pH 6, therefore the TRPV1 
mutants Y401A, D707A, T406D-D707A, and Y401A-D707A were challenged in the absence 
of extracellular Ca2+ with two consecutive series of application of pH6, as well as 0.3 and 
3.3 µM capsaicin. TRPV1-mediated currents were recorded in the whole-cell configuration 
applying voltage-ramps (-100 mV to +100 mV). Representative pH6 and capsaicin-induced 
TRPV1-mediated inward and outward currents as well as the corresponding ratio of 1st 
and 2nd responses were presented in Figure 44.  
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The analysis of the TRP domain mutant D707A revealed that pH6 and capsaicin induced 
similar responses in the 1st and 2nd application series, resulting in a ratio of about 1. 
Y401A-D707A TRPV1 receptor mutants showed slightly weaker responses in the first 
series of application of pH6 and 0.3 µM capsaicin, but gained full responsiveness after 
priming with 3.3 M µM capsaicin, resulting in ratios (1st vs. 2nd response) of 0.5 to 0.9, 
which indicates a slight sensitization to pH6 and 0.3 µM capsaicin. Moreover, Y401A and 
T406D-D707A also did not respond to pH6 and 0.3 µM capsaicin in the first application 
series, but again developed full responsiveness of the TRPV1 receptor after priming with 
3.3 µM capsaicin. The calculated ratios were below 0.4, indicating a strong sensitization of 
the TRPV1 receptor variants. These data show again that the mutations of the amino 
acids T406D and Y401A which are adjacent to the TRP domain, have severe consequences 
on TRPV1 function. The lack of pH6 or 0.3 µM evoked responses before the priming 
supports the hypothesis that TRP-domain adjacent structures, including Y401 and T406, 
affect the TRPV1 ion channel gating.  
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Figure 44. Proton-mediated activation of transition pathway mutants. Left panel: 
Representative inward (-100 mV) and outward (+100 mV) currents of (a) TRPV1Y401A, (b) 
TRPV1D707A, (c) TRPV1T406D-D707A, and (d) TRPV1Y401A-D707A. Low pH Ringer’s solution, 
0.3 µM, and 3.3 µM were applied in two consecutive series. Right panel: Ratio of 1st and 
2nd response to the same stimuli. Ratios of about 1 indicated no sensitization or 
desensitization, whereas ratios >1 represent desensitization and ratios <1 receptor 
sensitization. Mean ± sem of n = 6-10 independent measurements.  
In summary, the in vivo data demonstrated that the TRPV1-mediated nociception is highly 
modulated by the Cdk5 activity in sensory neurons. The behavioral study using the TRPV1 
agonist capsaicin and heat revealed that increased Cdk5 activity led to hyperalgesia and 
allodynia, whereas decreased Cdk5 activity induces hypoalgesia. These in vivo findings 
were transferred into a recombinant expression system to characterize the underlying 
molecular mechanisms in detail. The key result of the electrophysiological 
characterization was that the co-expression of TRPV1, Cdk5, and p35 prevents the Ca2+-
mediated desensitization. 
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Since, the kinase Cdk5 is able to phosphorylate TRPV1 at position T406 we generated 
several TRPV1T406 mutants to investigate the effect on receptor function. Particularly, we 
were interested in mimicking the phosphorylation of T406, by introducing a negatively 
charged amino acid. The key outcome was that the introduction of charged amino acids 
especially the negatively charged aspartic acid has severe consequences on TRPV1 
activation kinetics, desensitization, voltage activation, and single channel properties. 
Additionally, we could demonstrate that the use-dependent activation pattern of 
TRPV1T406D is based on an altered gating mechanism, which affects the TRPV1-mediated 
responses to capsaicin, low pH, and heat. The single-channel experiments revealed that 
the TRPV1T406D mutant directly affects the gating mechanism of the ion channel by 
prolonging one of the closed states. In order to investigate the altered TRPV1 gating 
mechanism in detail, we analyzed the TRPV1 structure and investigated the potential 
transition pathway by mutagenesis and electrophysiological characterization of functional 
properties. These data suggest that the TRPV1 linker domain, including T406, affects the 
TRP domain, which is connected to the pore forming TMD 6. Therefore, we conclude that 
the Cdk5-mediated phosphorylation of TRPV1 at position T406 affects the ion channel 
gating, by modifying the conformation of the TRP-domain adjacent linker domain. 
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7 Discussion 
The aim of this study was to improve the understanding of the signal transduction 
mechanisms in nociceptive neurons by characterizing the functional and conformational 
impact of Cdk5-mediated phosphorylation of the TRPV1 protein. To this end, we and our 
collaboration partners (NIH, Bethesda USA) performed several different experimental 
approaches such as behavioral testing of genetically engineered Cdk5 mice (Jendryke et 
al. 2016), as well as electrophysiological recordings, Ca2+ imaging experiments, and TIRF 
microscopy of transiently transfected CHO cells. The obtained data illustrate the impact of 
T406 phosphorylation or mutagenesis on the function of TRPV1 receptors. Moreover, the 
functional characterization of T406 mutants let us speculate on the conformational 
changes that could be involved in the gating mechanism of TRPV1 ion channels. Finally, 
we analyzed the potential transition pathway of TRPV1 activation and phosphorylation by 
investigating the effect of transition pathway mutants on TRPV1 function. The molecular 
mechanism of TRPV1 activation is of particular significance, since TRPV1 plays a key role 
in nociception. This modulation of TRPV1 contributes to the induction of 
hyperalgesia/allodynia or hypoalgesia and is a potential target for the future 
development of analgesic drugs. 
7.1 TRPV1 phosphorylation and nociception  
It is known that the kinase-mediated phosphorylation of TRPV1 induces hyperalgesia and 
allodynia in vivo. For instance, the studies of Caterina et al., and Davis et al. revealed that 
the PKA-mediated phosphorylation of the TRPV1 receptor has severe impact on the 
TRPV1 ion channel function and the TRPV1-mediated nociception in vivo (Caterina et al. 
2000; Davis et al. 2000). Moreover, it is known that the PKA or PKC-mediated 
phosphorylation of the receptor protein led to an increased sensitivity to capsaicin and 
heat in genetically engineered mice (De Petrocellis et al. 2001; Rathee et al. 2002; Bhave 
et al. 2003; Premkumar et al. 2004; Rosenbaum & Simon 2004). The same was also true 
for the CaMKII-mediated phosphorylation of TRPV1 (Jung et al. 2004). Therefore, we 
assume that the Cdk5-mediated phosphorylation has similar effects on TRPV1 function 
like its phosphorylation by PKA, PKC, or CaMKII. 
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In our joint study, Kulkarni et al. extended their in vivo analysis (Jendryke et al. 2016). 
They investigated the TPRV1-mediated pain responses of genetically engineered mice by 
means of the specific TRPV1 agonist capsaicin or noxious heat (45 °C). In mice 
overexpressing p35, the neuronal activator of Cdk5, they observed an increased Cdk5 
activity which induced hyperalgesia and/or allodynia. However, the conditional knockout 
of Cdk5 or the knockout of p35 in sensory neurons induced hypoalgesia. In conclusion, 
these results revealed that TRPV1-mediated nociception is modulated by the kinase Cdk5. 
We assume that the increased sensitivity to capsaicin or heat is due to the Cdk5-mediated 
phosphorylation of the TRPV1 receptor protein. This is in line with previous studies 
showing that the kinase-mediated phosphorylation of TRPV1 induces hyperalgesia and/or 
allodynia (Pareek et al. 2007; Pareek et al. 2006). Thus, we set out to investigate the 
TRPV1 function with regard to the Cdk5-mediated phosphorylation, by means of a 
detailed electrophysiological characterization of the TRPV1 receptor protein function.   
7.2 The molecular mechanism of TRPV1 phosphorylation  
The phosphorylation of TRPV1 receptors affects the ion channel function in different 
ways. The phosphorylation of TRPV1 increases the sensitivity and/or prevents the Ca2+-
dependent desensitization of the receptor protein. To the best of our knowledge, no in 
vitro data regarding the Cdk5-dependent phosphorylation of TRPV1 were available so far. 
Thus, we set out to analyze the TRPV1-mediated currents of transiently transfected CHO 
cells expressing TRPV1 or a combination of TRPV1, Cdk5, and the neuron specific Cdk5 
activator p35. TRPV1-mediated currents and Ca2+-dependent desensitization of TRPV1 
was induced by challenging cells with saturating capsaicin concentrations in the presence 
of extracellular Ca2+. Our data revealed that TRPV1-mediated currents strongly 
desensitize in presence of Ca2+, whereas the co-expression of Cdk5 and p35 prevented the 
Ca2+-induced acute desensitization of TRPV1-mediated currents. The analysis of the 
capsaicin concentration/response-relationship reveals that Cdk5 co-expression does not 
affect the TRPV1 sensitivity to capsaicin. Thus, we conclude that our findings were in line 
with the results of Mohapatra and Nau, the kinase-mediated phosphorylation of TRPV1 
decreases the Ca2+-dependent desensitization (Mohapatra & Nau 2003), and not in line 
with the results of Rathee et al. 2002 and Bhave et al. 2003 revealing that the PKC-
mediated phosphorylation of TRPV1 sensitizes the receptor to capsaicin and heat (Rathee 
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et al. 2002; Bhave et al. 2003). In general, TRPV1 sensitization or prevention of receptor 
desensitization has severe consequences on the TRPV1-mediated nociception in vivo. The 
sensitization of the receptor protein reduces the activation threshold of TRPV1 receptors, 
whereas prevention of the Ca2+-dependent desensitization reduces the decline of the 
stimuli induced responses. Both, receptor sensitization and prevention of receptor 
desensitization increases the net influx of cations through the TRPV1 pore, which leads to 
an intensified depolarization of the plasma membrane. Therefore, the TRPV1-mediated 
depolarization of the free nerve endings of the sensory neurons triggers the activation of 
voltage-gated Na channels. The subsequently increased influx of Na depolarizes the free 
nerve endings and initiates the formation of action potentials. In conclusion, the 
phosphorylation of TRPV1 increases the net influx of cations, which increases the 
depolarization of the free nerve endings, and leads to the increased generation of action 
potentials. Finally, the central nervous system can interpret the increased frequency of 
action potentials as pain. Moreover, the prolonged activation of sensory neurons and the 
increased influx of cations (Ca2+) can also induce protein degradation and/or cytotoxic 
processes that led to axon decline of sensory neurons (Kim et al. 2006; Reilly et al. 2008; 
Agopyan et al. 2004). To prevent the excessive influx of cations trough the TRPV1 ion 
channel pore, the desensitization of the TRPV1 ion channel reduces the net influx of 
cations. The underlying mechanism may involve an increase in the rate of entries into a 
desensitized state or a decrease in the rate of exits from desensitized states. In order to 
investigate this aspect in more detail we set out to analyze the TRPV1 function of 
TRPV1T406 receptor mutants.  
7.3 TRPV1T406 mutagenesis   
In general, protein phosphorylation can be inhibited by removing serine or threonine 
residues at putative phosphorylation sites, or be mimicked by introducing a bulky and 
negatively charged amino acid (aspartate or glutamate) by site directed mutagenesis of 
the target protein. Some of the previous mentioned TRPV1 studies also made use of 
TRPV1 receptor mutants in order to identify the phosphorylation sites or to investigate 
the effect of altered amino acid residues on TRPV1 function. In order to identify the PKA 
phosphorylation sites in the TRPV1 receptor Bhave et al. mutated the potential consensus 
sites (S6, S116, T144, T370, S502, S774, and S820) in the TRPV1 receptor with alanine.  
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They revealed that the PKA-mediated phosphorylation of TRPV1 at amino acid S116 is 
functionally relevant and prevents the Ca2+-dependent desensitization (Bhave et al. 2002). 
This was supported by the studies of Mohapatra and Nau, which showed that the PKA-
dependent phosphorylation can be mimicked by the introduction of negatively charged 
amino acids (Mohapatra & Nau 2003). Similarly, site-directed mutagenesis studies of 
TRPV1 were used to identiy the phosphorylation sites for CaMKII and Src kinase (Zhang et 
al. 2005; Jung et al. 2004). Numazaki et al. replaced the Ser residues S502 and S800 with 
alanine, in order to inhibit the PKC-mediated phosphorylation (Numazaki et al. 2002). In 
conclusion, these studies revealed that the mutagenesis of the TRPV1 phosphorylation 
sites into alanine prevent the kianse-mediated phosphorylation, whereas the introduction 
of aspartate mimics the phosphorylation. The TRPV1 consensus sites for kinase-mediated 
phosphorylation are far from the ion channel pore in the TRPV1 N- and C-terminus as well 
as in intracellular loops. However, the consensus sites are located in structures such as 
ankyrin repeats, linker domains and the TRP domain, which are part of the TRPV1 gating 
mechanism. In order to investigate this, we set out to generate several TRPV1 mutants in 
order to mimic or inhibit the Cdk5-mediated phosphorylation of the receptor protein. We 
replaced threonine 406 by the amino acids aspartate or alanine, respectively. Moreover, 
we were interested in the effect of amino acid residues such as histidine and proline on 
TRPV1 function, since these residues were characterized by different size and/or charge. 
Our data revealed that the introduction of both, negatively (Asp or Glu) as well as 
positively (Arg, His or Lys) charged amino acid residues, but also proline, inhibits the Ca2+-
dependent desensitization of TRPV1 receptors. Moreover, we found in TRPV1T406D and 
TRPV1T406E mutants an initially low stimulus sensitivity and very slow activation kinetics. In 
order to investigate the TRPV1T406D receptor variant in more detail, we analyzed also the 
initial TRPV1-mediated current as well as a second response to the same stimulus after 
priming the receptor protein. The data revealed that the prolonged activation of 
TRPV1T406D with capsaicin induces a markedly increased sensitivity and acceleration of 
TRPV1 activation kinetics. To the best of our knowledge, this use-dependent behavior of 
TRPV1 mutants was not yet described. Neither the kinase-mediated phosphorylation of 
TRPV1 nor the introduction of amino acid residues such as alanine leads to a slowed 
activation kinetics as we found in TRPV1T406D mutants.  
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Therefore, we suggest that in TRPV1T406D the protein conformation is altered, which 
affects the gating mechanism of the receptor protein and induces the use-dependent 
behavior. More precisely, we suggest that the aspartate at position 406 alters the 
conformation of the four TRPV1 subunits and that the binding of capsaicin to all four 
subunits is necessary to rearrange these conformational changes. Alternatively, during 
the maximal activation, the mutagenesis of amino acid T406 might increase the 
translocation of the TRPV1 receptor protein into the plasma membrane. Interestingly, 
Xing et al. and Liu et al. found that Cdk5 positively regulates the TRPV1 membrane 
trafficking in sensory neurons. Their studies revealed that Cdk5 is able to phosphorylate 
the motor protein KIF13B, which then promotes the trafficking process of TRPV1 to the 
plasma membrane. Furthermore, they found that this regulatory mechanism is connected 
to inflammatory heat-induced hyperalgesia (Liu et al. 2015; Xing et al. 2012). In order to 
address this, we investigated the stimulus-dependent receptor translocation by means of 
TIRF microscopy. We analyzed the fluorescence of GFP tagged TRPV1WT and TRPV1T406 
mutants in the plasma membrane of CHO cells. The data revealed that the GFP-
fluorescence of cells expressing GFP-TRPV1WT or GFP-TRPV1T406D is unaffected by 
challenging cells with a supramaximal concentration of capsaicin. Thus, we conclude that 
the slowed activation kinetics of TRPV1T406D is not due to an increased membrane 
trafficking of the receptor, but most likely due to functional and structural changes in the 
TRPV1 receptor protein.  
7.4 TRPV1T406D voltage-dependence  
The kinase-dependent phosphorylation of TRPV1 increases the voltage-dependence of 
the receptor protein (Matta & Ahern 2007; Premkumar & Ahern 2000). Thus, we set out 
to investigate the voltage-dependence of TRPV1WT, TRPV1T406A, and TRPV1T406D in detail 
by means of voltage-step protocols. Interestingly, hardly any voltage-dependent 
TRPV1T406D-mediated currents could be recorded before the initial application of 
capsaicin. A prolonged application of capsaicin significantly enhances the voltage-
dependence, which was also present up to 5 minutes after the capsaicin washout. To the 
best of our knowledge, this effect on the voltage-dependence of TRPV1 receptor was 
unknown. The introduction of negatively charged residues into the TRPV1 receptor, in 
order to mimic the PKA, PKC, or CaMKII mediated phosphorylation, induced the same 
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functional characteristics as the kinase-mediated phosphorylation. The mutated TRPV1 
receptors in the PKA, PKC, or CaMKII-kinase studies neither showed the use-dependent 
behavior nor the altered voltage-dependence we found in TRPV1T406D mutants. The 
analysis of TRPV1T406D revealed that the introduction of a negative residue (Asp) at amino 
acid T406 does not mimic the Cdk5-mediated phosphorylation of TRPV1. Thus, we 
assume that the mutagenesis of TRPV1 at residue T406 affects the gating mechanism of 
the ion channel in a different way than the Cdk5-mediated phosphorylation of TRPV1. In 
general, the phosphorylation of proteins is a dynamic process, which depends on several 
factors such as kinase activity or access to the consensus site. For instance, the Cdk5-
mediated phosphorylation of TRPV1 depends not only on the Cdk5 function but also on 
the functionality of the Cdk5 activator p35. Additionally, the Cdk5-mediated 
phosphorylation only affects the folded TRPV1 protein in the plasma membrane, 
whereas, the mutagenesis of the TRPV1 receptor could also affect the folding process of 
the four TRPV1 subunits. Notably is also that the voltage-dependent activation of TRPV1, 
which is probably the primary molecular mechanism that induces the opening of the ion 
channel pore, is affected by the T406D mutagenesis. The agonist-mediated activation 
such as binding of capsaicin or protons simply modulates the voltage-dependence of the 
TRPV1 receptors. Therefore, we assume that the introduction of aspartic acid at position 
T406 directly affects the gating mechanism that is potentially linked to the voltage sensor 
of the TRPV1 receptor protein.  
7.5 The TRPV1 ion channel sensitivity to capsaicin 
Capsaicin activates the TRPV1 receptor by binding to an intracellular binding site, which is 
formed by transmembrane domain 3 and 4 in each of the four subunits of the TRPV1 
receptor. We suggest that the binding of capsaicin induces conformational changes in the 
adjacent structures, which most likely facilitate the opening of the TRPV1 pore. The 
priming of the TRPV1T406D receptor work best at high concentrations of capsaicin. 
Therefore, we assume that the binding of capsaicin to the four binding sites of one TRPV1 
receptor is necessary to induce the conformational changes, which reverses the 
TRPV1T406D function. Since, the PKC-mediated phosphorylation of TRPV1 increases the 
receptor sensitivity to capsaicin (Bhave et al. 2003), we set out to investigate the impact 
of TRPV1T406 mutagenesis on the sensitivity to capsaicin.  
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The TRPV1 receptor protein sensitivity to capsaicin was investigated by analyzing the 
capsaicin concentration-response relationship before and after priming with 3.3 µM 
capsaicin. To prevent the Ca2+-dependent desensitization of TRPV1 receptors we recorded 
in absence of extracellular Ca2+. The data revealed that the sensitivity to capsaicin of 
TRPV1WT and most of the TRPV1T406 mutants was equal before and after the prolonged 
application of capsaicin. However, in TRPV1T406D and TRPV1T406E measurements, we found 
hardly any responses to capsaicin before the prolonged application of 3.3 µM capsaicin. 
But, after the priming of TRPV1T406D and TRPV1T406E receptors, we observed a significantly 
increased responsiveness to low capsaicin concentrations, which indicates a sensitization 
of these receptor proteins. The sensitization of TRPV1 by introducing negatively charged 
amino acids is in line with the previous mentioned studies. As mentioned before, the PKC-
mediated phosphorylation of TRPV1 can be mimicked by replacing the PKC-consensus site 
with alanine, which prevents the receptor protein sensitization (Mohapatra & Nau 2003; 
Studer & McNaughton 2010). The use-dependent concentration/response-relationship of 
TRPV1T406D does not correlate to the observations we made in the TRPV1, Cdk5, p35 co-
expression measurements. This supports the hypothesis that the introduction of aspartic 
acid at residue T406 affects the TRPV1 function in a different way than the Cdk5-
dependent phosphorylation. As mentioned before, the mutagenesis of TRPV1 affects 
every subunit of every receptor protein, whereas the Cdk5-dependent phosphorylation of 
TRPV1 is more variable.  
7.6 Proton and heat induced activation of TRPV1T406 mutants  
Since TRPV1T406D affects the capsaicin-induced gating mechanism of the TRPV1 receptor 
protein, we set out to investigate alternative activation mechanisms. Therefore, we 
investigated the proton and heat-mediated activation of TRPV1T406 mutants. The proton 
binding site is extracellularly located at the outer pore (Aneiros et al. 2011), thus we 
suggest that the proton-mediated activation of TRPV1 has a different activation 
mechanism than capsaicin. The analysis of the proton or heat-induced TRPV1-mediated 
currents revealed that the TRPV1T406 mutants carrying a negatively charged amino acid 
residue showed again a use-dependent behavior. Hardly any TRPV1-mediated response 
could be evoked in TRPV1T406D expressing cells by the initial stimulation with hot 
temperatures or low pH.  
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However, the prolonged activation of the TRPV1T406D with 3.3 µM capsaicin induced an 
increased responsiveness to heat and low pH. Therefore, we conclude that the 
introduction of aspartic acid at residue T406 does not directly affect the heat, low pH or 
capsaicin-mediated activation of TRPV1, but supports the hypothesis that the T406D 
mutation affects the TRPV1 gating mechanism.   
7.7 Single channel properties of TRPV1T406D receptors  
In order to investigate the gating mechanism of TRPV1 and TRPV1T406D in detail, we 
analyzed the single-channel properties. The analysis of single-channel properties is the 
most accurate method of ion channel characterization, since the function of one receptor 
protein is observed. The analysis of Studer and McNaughten revealed that the TRPV1 
gaiting has different open and closed states, which indicates a complex gating mechanism 
that includes several conformational changes. Based on their model, the TRPV1 gating is 
subdivided in three open and four closed states, which were changed by agonist 
mediated activation, phosphorylation or dephosphorylation (Studer & McNaughton 
2010). These findings were in line with our single-channel analysis. We found also three 
open and four closed states in TRPV1WT and TRPV1T406D. Additionally, we found that the 
low open probability of TRPV1T406D, before priming the receptor, is based on the 
increased length of closed state C4. In conclusion, the TRPV1T406D single-channel 
properties are in line with our previous electrophysiological results and support the 
hypothesis that the gating mechanism of TRPV1T406D is modulated. All TRPV1T406D 
experiments revealed that the initial non-liganded TRPV1T406D conformation shows a 
limited ion channel function, whereas the priming of the receptor led to wild-type 
(sensitized) like ion channel characteristics. Therefore, we suggest that the introduction 
of aspartic acid at position T406 induces conformational changes in the TRPV1 protein, 
which affect the ion channel gating mechanism.  
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7.8 The high resolution structure of TRPV1  
Our data demonstrate that one amino acid in the intracellular N-terminus of the TRPV1 
can affect the ion channel gating mechanism. Position T406 of the TRPV1 sequence is 
neither located within the capsaicin binding site or ion channel pore, nor directly related 
to the voltage sensor or another identified region of the protein responsible for heat or 
proton activation (Choi et al. 2014). Therefore, to shed light on the TRPV1 gating 
mechanism we made use of the recently published high resolution (3-4 Å) structures of 
rTRPV1 (Cao et al. 2013). Three distinct rTRPV1 structures are available in the data bases 
representing the closed, intermediate, and open state. Comparing these structures with 
focus on T406 revealed interesting details in the protein conformation. It appears that 
T406 is located in a flexible linker in close proximity to the TRP-domain, and the 
conformation of this linker seems to differ between the closed and open state. In the 
closed state T406 is part of the flexible linker, whereas in the open state T406 is 
integrated into a α-helix. Furthermore, to scrutinize the putative role of T406 in the gating 
process of the pore, we looked at the all-atom simulation of TRPV1 by Zheng and Qin 
(Zheng & Qin 2015), which is based on the high resolution structure of rTRPV1 by (Cao et 
al. 2013). Based on their model the transition pathway includes four functional parts 
listed in the motional order: i) ankyrin repeats domain (ARD) residue 110-357  
membrane proximal domain (MPD) residue 358-439 (contains T406)  C-terminal 
domain (CTD) 691-719 (including TRP-box)  Transmembrane domain (TMD) 5-6 (Zheng 
& Qin 2015). Additionally, the authors analyzed the van der Waals (vdW) energy of the 
intracellular domains in the closed and open state. Within the intracellular domain, they 
found that several amino acids have higher vdW energy in the open state than in the 
closed state. Particularly T406, R409 and M412 showed high vdW energy differences and 
are strategic positioned interfacing the MPD, the CTD and the TMD. In conclusion these 
findings support the hypothesis that T406 participates in TRPV1 ion channel gating.   
In order to investigate a potential transition pathway we (in cooperation with Prof. C. 
Ziegler (Department of Biophysics, University of Regensburg)) analyzed the TRPV1 3D 
structures provided by Cao et al., and Liao et al.  
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The aim was to identify potential structures or residues of the TRPV1 receptor protein, 
which connect the Cdk5-mediated phosphorylation or mutagenesis at position T406 to 
the gating mechanism of TRPV1 ion channels. Therefore, we analyzed the relative 
distance between the linker domain, including T406, and the TRP domain, which is 
connected to the pore forming TMD 6. The analysis revealed that the distance between 
amino acid Y401 (linker domain) and D707 (TRP domain) is different in the open or closed 
ion channel. In the closed state we measured 3.1 Å between these amino acid residues, 
whereas, in the intermediate and open state we found a distance of 2.6 Å, which is a 
distance that facilitates hydrogen bounds. Thus, we assumed that the phosphorylation or 
mutagenesis of T406 affects the potential interaction between the linker domain (Y401) 
and the TRP-domain (D707). Moreover, the analysis revealed that residue R499 is in close 
proximity to the residues of D707 and Y401. Interestingly, R499 is close to the PKA 
phosphorylation site S501, in the intracellular loop between transmembrane domain 2 
and 3, thus we assume that the PKA-dependent phosphorylation of S501 may induce 
similar functional and conformational changes as the Cdk5-mediated phosphorylation at 
T406.  
7.9 The TRPV1 transition pathway of Cdk5-mediated phosphorylation  
In order to investigate the TRPV1 gating mechanism, which is affected by the 
phosphorylation and/or mutagenesis of amino acid T406, we set out to analyze the 
potential transition pathway in detail. Thus, we generated several TRPV1 receptor protein 
mutants and characterized the ion channel function by means of electrophysiological 
recordings. We assume that the potential transition pathway of TRPV1WT or TRPV1T406D 
receptor proteins is interrupted by introducing alanine at amino acid residue Y401, R499, 
and D707. The charge or polarity of amino acid residues facilitates the formation of 
hydrogen bounds, which is necessary for the organization of tertiary structures of 
proteins. However, the amino acid characteristics of alanine prevent the formation of 
hydrogen bounds, which might induce an altered protein conformation. Thus, we assume 
that the mutagenesis of the transition pathway affects the functional properties of TRPV1 
and TRPV1T406D. Interestingly, we found in all transition pathway mutants a significantly 
reduced desensitization, in particular in the D707A, Y401A mutants as well as in the 
double mutant Y401A-D707A.  
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These results supports our hypothesis that the membrane proximal domain (MPD) and 
the TRP-domain directly interact and that the interruption of the suggested hydrogen 
bounds affect the ion channel gating. Moreover, we assume that the close proximity of 
T406 to Y401 affects the interaction of Y401 and D707. However, the mutagenesis of 
R499A also prevents the Ca2+-dependent desensitization of TRPV1 receptors. Therefore, 
we suggest that not only the direct interaction via hydrogen bounds between Y401 and 
D707 are essential for the TRPV1 ion channel gating, but also the electrostatic properties 
of the adjacent amino acid residue R499. The close proximity of the phosphorylation sites 
S501 (PKA) to R499 might indicate that the PKA-mediated phosphorylation of TRPV1 also 
affects the gating mechanism. The interaction of R499, which resides in the intracellular 
loop between TMD 2 and 3, with the TRP-domain could be modified. In conclusion, we 
suggest that the phosphorylation of T406 or S501 has severe consequences on the 
flexibility of the TRP-domain. Since the TRP-domain is directly connected to the pore 
forming TMD6, we suggest this transition pathway has severe consequences for the 
opening and/or closing of the lower gate of the TRPV1 ion channel pore.  This hypothesis 
is supported by the functional characterization of transition-pathway mutants D707A and 
R499A, revealing the same use-dependent activation as TRPV1T406D. Analyzing the 
sensitivity of transition pathway mutants to capsaicin or protons revealed that these 
receptor variants were insensitive to the stimulus before priming the receptor protein, 
whereas the maximal activation increases the responsiveness. However, the analysis of 
the current-voltage relationship revealed that the mutagenesis of the transition pathway 
did not change the voltage-dependence of the TRPV1 receptors. In conclusion, the 
mutagenesis of the transition pathway revealed that the gating mechanism of the TRPV1 
receptor protein highly depends on the conformational changes and interactions that 
occur between the membrane proximal domain (MPD) and the TRP-domain. These 
conformational changes affect in particular the activation and desensitization kinetics of 
TRPV1 receptor proteins.  
7.10 The Ca2+-dependent desensitization of TRPV1 mutants  
The Ca2+-dependent desensitization of TRPV1 receptor proteins is important for ion 
channel modulation, since, the unregulated influx of Ca2+ into cells provokes cell death 
(Studer & McNaughton 2010; Kim et al. 2006; Agopyan et al. 2004; Reilly et al. 2008).  
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As described before, the TRPV1 desensitization is due to the calcineurin-dependent 
dephosphorylation of the receptor protein. However, we know very little about the 
conformational changes that are induced by dephosphorylation or phosphorylation of 
TRPV1 receptor proteins. Since, calcineurin is activated by the Ca2+/calmodulin complex 
the accurate interaction between these molecules is required. The N- and C-termini of the 
TRPV1 receptor are important players in TRPV1 desensitization. Numazaki et al. found 
that calmodulin binds at the C-terminus (amino acid 765-800) of TRPV1. They revealed 
that disruption of the calmodulin binding site prevents the Ca2+-dependent receptor 
desensitization (Numazaki et al. 2003). Similar results were found by Joseph et al. by 
analyzing the Ca2+ dependent desensitization of TRPV1-TRPV3 chimera. They replaced the 
C-terminus of TRPV1 with the C-terminus of the TRPV3 receptor protein, and found that 
the chimeric receptor does not desensitize during heat activation (Joseph et al. 2013). 
Additionally, it is known that the N-terminal binding of ATP to the TRPV1 receptor at 
amino acid K155 prevents the Ca2+-dependent desensitization (Lau et al. 2012). Since we 
found a strong Ca2+-dependent desensitization in TRPV1WT and TRPV1T406 mutants, we 
suggest that our TRPV1 mutations did not affect the ATP or calmodulin binding to the N- 
and C–terminus. Thus, we assume that the Ca2+-dependent dephosphorylation is active in 
all TRPV1T406 and transition pathway mutants, but the conformational changes in the 
TRPV1 transition pathway prevents the ion channel desensitization. As discussed before, 
the prevention of Ca2+-dependent desensitization has severe consequence for the TRPV1-
mediated nociception. The prolonged influx of cations would initially increase the 
depolarization, which facilitates the action potential generation, but the unregulated 
influx of Ca2+ could induce axon decline or cell death.  
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8 Conclusion  
The TRPV1T406D and the transition pathway mutants not only showed a reduced 
desensitization but also a use-dependent activation. Even though the TRPV1 voltage 
sensing mechanism is not fully understood yet, we suggest that the use-dependent 
activation and the altered voltage-dependence of TRPV1T406D are based on an altered ion 
channel structure. The structural and electrophysiological analysis indicates that the 
mutagenesis of TRPV1 at residue T406D or at the transition pathway induces several 
conformational changes in the receptor protein. These changes affect the voltage-
dependence and other ion channel properties by interrupting the transition pathway of 
the gating mechanism of the TRPV1 receptor protein. Moreover, we suggest that the 
prolonged activation of TRPV1T406D with capsaicin induces structural rearrangements of 
the receptor protein, which led to receptor function that is similar to the TRPV1WT. To 
shed light on the conformational changes that occur during the priming of TRPV1T406D it 
would be necessary to resolve the structure of the receptor protein before and after 
priming. These structures would clearly demonstrate the effect of the T406D mutation on 
the TRPV1 structure. By means of such high resolution 3D structures we would be able to 
identify potential hydrogen bounds and/or conformational alterations of the TRPV1 
receptor. It would be also interesting to investigate the effect of TRPV1T406D on the signal 
transduction in sensory neurons. We would assume that the initially prevented influx of 
cations trough the TRPV1T406D ion channel pore would result in neurons that were less 
excitable. However, the prolonged activation with high concentrations of capsaicin would 
increase the cation influx and would result in neurons that were more excitable. 
Moreover, we would assume that the expression of TRPV1T406D in the free nerve endings 
of sensory neurons induce a complex TRPV1-mediated nociceptive behavior in vivo. The 
phenotype could have an initially low responsiveness to TRPV1-mediated noxious stimuli 
(hypoalgesia), but the prolonged activation would induce hyperalgesia or allodyina.  
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9 Materials  
9.1 Consumables 
Borosilicate glass pipette GB150EFT-10 Science Products GmbH,    
      Hofheim, Germany  
Cell culture dish  Ø 10 cm TPP, Trasadingen, Switzerland 
    Ø 3.5 cm Sarstedt AG & Co, Nümbrecht, Germany 
Cell scraper     TPP, Trasadingen, Switzerland 
Centrifuge tube  15 and 50 ml Corning, Tweksbury, USA 
Coverslip    Ø 12, 25 mm  VWR International, Radnor, USA 
Eppendorf tube  0.5, 1.5, 2 ml Eppendorf, Hamburg, Germany 
Object slide 76 x 26 mm Paul Marienfeld GmbH,    
  Königshofen, Germany 
sterile filter   0.2 µM Sarstedt AG & Co, Nümbrecht, Germany 
    70 µM  BD Bioscience, Franklin Lakes, USA 
9.2 Chemicals 
Acrylamide  Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Agarose  Peqlab Biotechnologie GmbH,   
 Erlangen, Germany 
BaCl2      Merck, Darmstadt, Germany 
CaCl2      Carl Roth GmbH & Co KG, Karlsruhe, Germany 
Capsaicin     Alomone labs, Jerusalem, Israel 
Capsazepine      Cayman Chemical, Michigan, USA 
DMSO      Sigma-Aldrich Co., Irvine, UK 
Materials 
101 
 
dNTP      Bioline GmbH, Luckenwalde, Germany 
EDTA      Sigma-Aldrich Co., Steinheim, Germany 
EGTA      AppliChem, Darmstadt, Germany 
Ethidium bromide    Sigma-Aldrich Co., Steinheim, Germany 
Glycerol     Sigma-Aldrich Co., St. Louis, USA 
HEPES      Sigma-Aldrich Co., Steinheim, Germany 
KCl      Carl Roth GmbH & Co KG, Karlsruhe, Germany 
MgCl2      Carl Roth GmbH & Co KG, Karlsruhe, Germany 
NaCl      Carl Roth GmbH & Co KG, Karlsruhe, Germany  
Orange DNA loading Dye   Peqlab Biotechnologie GmbH,   
      Erlangen, Germany 
Penicillin-streptomycin   Sigma-Aldrich Co., St. Louis, USA 
Trypsin-EDTA     Life technologies GmbH, Darmstadt,  
      Germany 
9.3 Enzymes and buffers 
Restriction enzyms  New England Biolabs GmbH,  
 Frankfurt a.M., Germany 
Buffer 2  New England Biolabs GmbH,    
Frankfurt a.M., Germany 
Buffer Red     Qiagen, Hilden, Germany 
CutSmart Buffer  New England Biolabs GmbH,   
 Frankfurt a.M., Germany 
Ligase Buffer     Promega GmbH, Mannheim, Germany 
Phosphate-buffered saline   Sigma-Aldrich Co., St. Louis, USA 
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PFUltra HF Polymerase   Aglient Technologies, Santa Clara, USA 
PFUltra HF Reaction Buffer   Aglient Technologies, Santa Clara, USA 
RKT Buffer     Quiagen GmbH, Hilden, Germany 
T4 Ligase     Promega GmbH, Mannheim, Germany 
T4 Ligase buffer  New England Biolabs GmbH,   
 Frankfurt a.M., Germany 
Taq Polymerase    Roche, Basel, Switzerland 
9.4 Cell culture media  
Alpha MEM Eagle    PAN-Biotech GmbH, Aidenbach, Germany 
DMEM      Life technologies GmbH, Darmstadt,  
      Germany 
Fetal calf serum    Sigma-Aldrich Co., St. Louis, USA 
LB Medium     Carl Roth GmbH & Co KG, Karlsruhe,  
      Germany 
Opti-MEM     Life technologies GmbH, Darmstadt, 
       Germany 
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9.5 Solutions 
Ampicilin stock solution   100 mg/ml in H2O 
Ca2+- Ringer’s extracellular solution:  140 mM NaCl  
(pH 7.35) 290 ± 10 mosmol/kg  5 mM KCl  
      2 mM CaCl2  
      2 mM MgCl2  
      10 mM HEPES  
Ringer’s extracellular solution:  140 mM NaCl  
Ca2+-free 290 ± 10 mosmol/kg  5 mM KCl  
(pH 7.35)     5 mM EGTA  
      2 mM MgCl2  
      10 mM HEPES  
Pipette Solution A:    140 mM CsCl  
(pH 7.35) 300 ± 10 mosmol/kg  1 mM MgCl2  
      0.1 mM CaCl2  
      5 mM EGTA  
      10 mM HEPES  
Pipette Solution B:    145 mM CsCl  
(pH 7.35) 300 ± 10 mosmol/kg  1 mM CaCl2  
      2 mM MgCl2  
      11 mM EGTA  
      2 mM HEPES  
LB-Agar     15 g Agar pro 1 L LB-Medium 
LB (Luria-Bertani)-Medium:   10 g/l Trypton  
(pH 7.4)     5 g/l Yeast extract  
      10 g/l NaCl 
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TBE buffer:     0.9 M Tris  
      0.9 M Borsäure  
      4 mM EDTA 
Trypsin-EDTA-Solution:    0.5 g/l Trypsin  
      0.2 g/l EDTA  
SOC medium     10 mM NaCl  
      10 mM MgCl2  
      10 mM MgSO4  
      20 mM glucose  
      2% tryptone  
      0.5% yeast extract  
9.6 Devices 
Cell culture microscope Olympus IX70   Olympus, Tokyo, Japan  
4x Objective   UPlanFI 0.13 Ph1 Olympus, Tokyo, Japan  
10x Objective   0.30 Ph2  Olympus, Tokyo, Japan 
20x Objective   LCPlan 0.4   Olympus, Tokyo, Japan 
Patch-clamp microscope 1 Axio VertA1  Carl Zeiss GmbH, Jena, Germany 
10x Objective   A-Plan 0.25 Ph1 Carl Zeiss GmbH, Jena, Germany 
40x Objective   LD-Plan-Neofluar Carl Zeiss GmbH, Jena, Germany 
    0.6 Ph2 Korr  
63x Objective   LD-Plan-Neofluar Carl Zeiss GmbH, Jena, German 
    0.75 Korr  
Patch-clamp microscope 2 Axiovert 35M  Carl Zeiss GmbH, Jena, Germany 
5x Objective   CP-Acromat  Carl Zeiss GmbH, Jena, Germany 
    0.12 
10x Objective   LD-Plan-Neofluar Carl Zeiss GmbH, Jena, Germany 
    0.3  
32x Objective   Acrosigmat  Carl Zeiss GmbH, Jena, Germany 
    0.4 Ph1 
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Light source   HXP 75W  Osram GmbH, Munich, Germany 
    XBO 75W/2  Osram GmbH, Munich, Germany 
Patch-clamp amplifier EPC-10   HEKA Electronic, Lamprecht,  
       Germany 
Micromanipulator:  1U RACK  Scientifica, Uckfield, UK   
    MHW-103  Narishige, London, UK 
Perfusion system: VM8 perfusion Ala Sientific Instruments,   
Farmigdale, USA 
Faraday cage  AMETEK GmbH, Meerbusch,  
 Germany   
Vibration damping table    TMC, Peabody, USA 
Centrifuges:   Biofuge pico  Thermo Scientific, Rockford, USA  
    Centrifuge 5415R Eppendorf, Hamburg, Germany  
    Megafuge 1.0  Thermo Scientific, Rockford, USA  
    Megafuge 2.0 R Thermo Scientific, Rockford, USA 
DMZ universal puller  Zeitz-Instruments GmbH, Munich, 
Germany 
Incubator Heracell 150    Thermo Scientific, Rockford, USA 
Nanodrop  Nanodrop Technologies Inc.,  
Wilmington, USA 
Neubauer chamber     Brand GmbH & Co. KG,   
       Wertheim, Germany 
ThermoCycler      Bio-Rad, Laboratories, GmbH,  
       Munich, Germany 
Sterile work bench  Herasafe KS12 ThermoScientific, 
Waltham, USA 
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9.7 Software 
IGOR Pro      WaveMetrics, Oregon, USA 
PatchMaster      HEKA Electronic, Lamprecht, Germany 
Pulse       HEKA Electronic, Lamprecht, Germany 
PulseFit      HEKA Electronic, Lamprecht, Germany 
SnapGene      GSL Biotech, Chicago, USA 
PyMol 1.6      Schrödinger, LLC,    
       Mannheim/Munich, Germany 
9.8 DNA Oligonucleotides: 
9.8.1 Overlap extension PCR primer 
Forward primer A:   5’-CTC TGG CTA ACT AGA GAA CCC ACT GC-3’  
Reverse primer B:   5’-CTG ATC AGC GAG CTC TAG CAT TTA GG-3’ 
TRPV1 T406A:  
Reverse primer A:  5’-CAT GTC ATG ACG GTT AGG GGC-3’    
Forward primer B:  5’-ATC GCT TAC AGC AGC AGT GAG GC-3’    
TRPV1 A406D: 
Reverse primer A:  5’-CAT GTC ATG ACG GTT AGG GTC-3’    
Forward primer B:  5’-AT CGC TTA CAG CAG CAG TGA GGA-3’    
TRPV1 D406E:  
Reverse primer A:  5’-CAT GTC ATG ACG GTT AGG TTC-3’    
Forward primer B:  5’-G CTT ACA GCA GCA GTG AGG AAC-3’    
9.8.2 pGEM-T Vector cloning primer 
Restriction site primer 
BstEII forward:   5‘-CTG GTG ACC CTC TTG GTG GAG-3’  
SacII reverse:   5‘-GTA GGC AGC CGC GGT GAA GAT GAT C-3’  
SacII forward:   5‘-GAT CAT CTT CAC CGC GGC TG-3’  
Xba reverse:   5‘-CAC TAT AGA ATA GGG CCC TCT AGA TGC ATG-3’ 
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Mutagenesis primer 
TRPV1 T406R:   
Reverse primer A:  5’-GTC ATG ACG GTT AGG TCT CTC ACT GCT GCT GTA-3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG AGA CCT AAC CGT CAT GAC-3’  
TRPV1 T406Y:  
Reverse primer A:  5’-GTC ATG ACG GTT AGG GTA CTC ACT GCT GCT GTA-3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG TAC CCT AAC CGT CAT GAC-3’  
TRPV1 T406H:   
Reverse primer A:  5’-GTC ATG ACG GTT AGG GTG CTC ACT GCT GCT GTA-3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG CAC CCT AAC CGT CAT GAC-3’  
TRPV1 T406K:   
Reverse primer A:  5’-GTC ATG ACG GTT AGG TTT CTC ACT GCT GCT GTA-3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG AAA CCT AAC CGT CAT GAC-3’  
TRPV1 T406I:   
Reverse primer A:  5’-GTC ATG ACG GTT AGG TAT CTC ACT GCT GCT GTA-3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG ATA CCT AAC CGT CAT GAC-3’  
TRPV1 T406P:  
Reverse primer A:  5’-GTC ATG ACG GTT AGG GGG CTC ACT GCT GCT GTA-3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG CCC CCT AAC CGT CAT GAC-3’  
TRPV1 T406M:  
Reverse primer A:  5’-GTC ATG ACG GTT AGG CAT CTC ACT GCT GCT GTA -3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG ATG CCT AAC CGT CAT GAC -3’  
TRPV1 T406F:   
Reverse primer A:  5’-GTC ATG ACG GTT AGG GAA CTC ACT GCT GCT GTA -3’  
Forward primer B:  5’-TAC AGC AGC AGT GAG TTC CCT AAC CGT CAT GAC -3’  
TRPV1 P407A:   
Reverse primer A:  5’-CAT GTC ATG ACG GTT AGC GGT CTC ACT GCT GCT -3’  
Forward primer B:  5’-AGC AGC AGT GAG ACC GCT AAC CGT CAT GAC ATG -3’  
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TRPV1 D707A: 
Reverse primer A:  5‘-AGC TCT TCT CTG TAG CCA GGA TGG TG-3’  
Forward primer B:  5‘-CAC CAT CCT GGC TAC AGA GAA GAG CT-3’ 
TRPV1 R499A:  
Reverse primer A:  5‘-GG TCG CGC CTG CAG GAA ATA TTG AAT CC-3’  
Forward primer B:  5‘-CAA TAT TTC CTG CAG GCG CGA CCA TCC CTC-3’ 
TRPV1 Y401A:  
Reverse primer A:  5‘-C ACT GCT GCT GGC AGC GAT CAC CTC C-3’  
Forward primer B:  5‘-G GAG GTG ATC GCT GCC AGC AGC AGT G-3’ 
9.8.3 TRPV1-GFP fusion protein Primer 
rTRPV1-AfeI-F:  5‘-AAA AGC GCT AGG ATG GAA CAA CGG GCT-3’  
rTRPV1-ApaI-R:  5’- A AAG GGC CCT CTC CCC TGG GAC CAT GGA A-3’ 
9.8.4 Sequencing Primer 
pGEM-T sequencing primer 
Reverse M13:   5’-AGC GGA TAA CAA TTT CAC ACA GGA-3’   
Forward M13:   5’-CGC CAG GGT TTT CCC AGT CAC GAC-3’  
pCDNA3 sequencing primer 
Forward pCDNA3 T7:  5’-TAA TAC GAC TCA CTA TAG GG-3’  
Reverse pCDNA BGH:  5’-TAG AAG GCA CAG TCG AGG-3’  
TRPV1_550:   5'-GTC TGC TAA AAG CCA TGC TCA A -3'  
TRPV1_1550:   5'-CCC TAT AAG CTG AAA AAC ACC -3' 
TRPV1-GFP sequencing primer 
rV1-Y401_B:   5‘-C ACT GCT GCT GGC AGC GAT CAC CTC C-3’  
rV1-Y401_F:   5’-G GAG GTG ATC GCT GCC AGC AGC AGT G-3’  
eGFP-50-R:   5’-TT GCC GGT GGT GCA GAT G-3’  
eGFP-200-F:   5’-CAC TAC CTG AGC ACC CAG T-3’  
SV40-R:   5’- GAT GCT ATT GCT TTA TTT GTA ACC ATT A-3’ 
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